Malignant neoplasm of colon

C3_COLON

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Cause of death: ICD-10 — C18 Cause of death: ICD-9 — 153 Cause of death: ICD-8 — 153 Cancer registry: Topography ICD-O-3 — C18 Cancer registry: Morphology ICD-O-3 — ANY Cancer registry: Behaviour codes — 3 2 out of 7 registries used, show all original rules.	6568
4. Check minimum number of events None	6568
5. Include endpoints None	6568
6. Filter based on genotype QC (FinnGen only)	6364

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF9

NAME	C3_COLON
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C18
COD_ICD_9	153
COD_ICD_8	153
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C18
CANC_TOPO_EXCL
CANC_MORPH	ANY
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of colon based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Colon adenocarcinoma

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	6364	2898	3466
Unadjusted period prevalence (%)	1.33	1.03	1.59
Median age at first event (years)	69.62	68.50	70.55

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
6567: Matched controls
65656

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

C18.90

ICD-10 Finland

Malignant tumor in unspecified location in the colon without histology

3118.9

321.2

308

JAL30

NOMESCO Finland

Omentectomy

40.3

316.2

192

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

5.0

314.4

733

1610

C18.29

ICD-10 Finland

Malignant tumor of the ascending colon or other unspecified histology

+∞

314.1

299

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

5.3

313.1

673

1378

A04AA55

ATC

palonosetron, combinations; systemic

+∞

308.8

294

C18.30

ICD-10 Finland

Malignant tumor of flexura hepatica without histology

+∞

307.7

293

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

1532.7

307.7

557

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

41.0

307.7

840

234

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

9.3

307.7

1065

1341

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

307.7

499

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

4185.0

307.7

404

JN3BD

NOMESCO Finland

Extensive abdominal CT

4.5

307.7

1145

2952

L03AA02

ATC

filgrastim; parenteral

100.1

307.7

232

TPX10

NOMESCO Finland

Implantation of vascular injection port

11.6

307.7

505

468

130

Kela drug reimbursment

Malignant tumour

+∞

307.7

3102

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

307.7

320

Z51.5

ICD-10 Finland

Palliative care

10.6

307.7

1186

1343

A04AA01

ATC

ondansetron; systemic, rectal

13.8

307.7

795

651

JFB44

NOMESCO Finland

Laparoscopic left hemicolectomy

173.8

307.7

377

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

+∞

307.7

339

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

307.7

1198

JN4AD

NOMESCO Finland

Body CT examination

11.7

307.7

1570

1710

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

4230.2

307.7

408

L02AE02

ATC

leuprorelin; implant, parenteral

51.9

307.7

211

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

1054.1

307.7

1061

L01BC06

ATC

capecitabine; oral

+∞

307.7

2320

WZC00

NOMESCO Finland

Treatment plan or consultation

3.4

307.7

2628

10849

N02AA05

ATC

oxycodone; systemic

3.5

307.7

1741

6135

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

282.6

307.7

1402

TPH07

NOMESCO Finland

Cathetrisation of artery

5.1

307.7

1541

3758

JFB30

NOMESCO Finland

Right hemicolectomy

147.3

307.7

1311

111

C18.0

ICD-10 Finland

Malignant neoplasm: Caecum

+∞

307.7

426

JFB46

NOMESCO Finland

Resection of sigmoid colon

25.0

307.7

482

207

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

9923.7

307.7

874

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

+∞

307.7

311

JAL20

NOMESCO Finland

Excision or destruction of lesion of peritoneum

109.0

307.7

170

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

233.5

307.7

690

WX408

NOMESCO Finland

General anesthesy, balanced

3.8

307.7

2415

8669

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

307.7

886

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

446.7

307.7

681

8140/3-C18.4

ICD-O-3

Adenocarcinoma, NOS, of transverse colon

+∞

307.7

411

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

+∞

307.7

430

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

+∞

307.7

606

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

7.5

307.7

1471

2447

JFB43

NOMESCO Finland

Left hemicolectomy

60.5

307.7

366

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

307.7

1090

C18.2

ICD-10 Finland

Malignant neoplasm: Ascending colon

+∞

307.7

376

D75

ICPC

Malignant neoplasm colon/rectum

292.0

307.7

385

A79

ICPC

Malignancy NOS

107.6

307.7

178

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

307.7

353

WX402

NOMESCO Finland

General anaesthesia

3.6

307.7

1656

5553

UJF32

NOMESCO Finland

Coloscopy

9.5

307.7

4367

11308

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

4.7

307.7

895

2111

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

8.7

307.7

628

785

JN4BD

NOMESCO Finland

Extensive body CT

19.4

307.7

2053

1505

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

307.7

818

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

9647.2

307.7

853

H02AB02

ATC

dexamethasone; systemic

79.3

307.7

1783

307

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

307.7

889

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

131.8

307.7

290

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

307.7

736

WF002

NOMESCO Finland

Radical radiotherapy

57.2

307.7

253

A03FA01

ATC

metoclopramide; systemic, rectal

13.0

307.7

3054

4103

C18.31

ICD-10 Finland

Malignant tumor of flexura hepatica invasive carcinoma

+∞

307.7

400

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

23.5

307.7

929

457

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

48.7

307.7

203

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

393.1

307.7

371

116

Kela drug reimbursment

Prostate cancer

+∞

307.7

310

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

307.7

1719

ZXE20

NOMESCO Finland

More than three and less than five hours

3.7

307.7

1434

4630

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

307.7

1700

JN4CD

NOMESCO Finland

Very extensive body CT

16.5

307.7

577

380

WX302

NOMESCO Finland

Thoracal epidural anesthesy

32.3

307.7

1435

564

B01AB10

ATC

tinzaparin; parenteral

5.6

307.7

1119

2306

WF049

NOMESCO Finland

Radiotherapy of metastasis

724.0

307.7

344

C61

ICD-10 Finland

Malignant neoplasm of prostate

452.4

307.7

540

ZX120

NOMESCO Finland

Intravenous

4.4

307.7

941

2382

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

15195.4

307.7

1247

JFB47

NOMESCO Finland

Laparoscopic resection of sigmoid colon

26.1

307.7

485

200

B01AB05

ATC

enoxaparin; parenteral

5.0

307.7

3603

12944

C18.40

ICD-10 Finland

Malignant tumor of the transverse colon without histology

+∞

307.7

342

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

307.7

476

WZC30

NOMESCO Finland

Teaching

5.4

307.7

1721

4052

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

45.4

307.7

328

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

10442.5

307.7

913

JAH00

NOMESCO Finland

Laparotomy

8.2

307.7

466

609

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

572.8

307.7

669

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

8.5

307.7

649

834

A04AA02

ATC

granisetron; systemic, transdermal

1102.9

307.7

1525

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

307.7

681

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.9

306.7

1024

2961

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

304.5

290

JN3AD

NOMESCO Finland

Abdominal CT examination

3.7

301.4

1130

3533

L02BG04

ATC

letrozole; oral

32.9

299.0

192

C18.11

ICD-10 Finland

Malignant tumor of the appendix invasive carcinoma

+∞

289.7

276

WF003

NOMESCO Finland

Adjuvant radiotherapy

146.1

286.2

143

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

11.9

285.4

293

256

115

Kela drug reimbursment

Breast cancer

+∞

284.4

271

XX3DW

NOMESCO Finland

Time consuming IT work

4.9

275.6

647

1425

C18.51

ICD-10 Finland

Malignant tumor of flexura hiealis invasive carcinoma

+∞

274.9

262

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

274.9

262

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

9.0

274.7

347

405

WW500

NOMESCO Finland

Blood transfusion

7.6

272.9

398

552

JFB00

NOMESCO Finland

Partial resection of small intestine

10.3

268.2

304

307

JFF10

NOMESCO Finland

Loop enterostomy

49.6

267.9

155

PJA12

NOMESCO Finland

Sentinel node biopsy

677.5

265.7

261

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

2490.6

259.9

250

JFF23

NOMESCO Finland

Transversostomy

27.8

259.6

176

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

24.9

258.2

182

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

256.9

245

L01BC59

ATC

trifluridine, combinations; systemic

+∞

255.9

244

JFB54

NOMESCO Finland

Laparoscopic resection of sigmoid colon with partial proctectomy

109.6

251.4

129

L03AA13

ATC

pegfilgrastim; parenteral

835.8

247.5

242

HAC20

NOMESCO Finland

Total mastectomy

126.3

245.0

124

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

241.1

230

C18.60

ICD-10 Finland

Malignant tumor of the descending colon without histology

+∞

240.0

229

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

24.0

239.3

171

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

237.9

227

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

234.8

224

JFH00

NOMESCO Finland

Total colectomy and ileorectal anastomosis

51.0

234.8

135

JFB50

NOMESCO Finland

Other resection of colon

43.7

230.2

137

D64.9

ICD-10 Finland

Anaemia, unspecified

2.9

230.1

1266

4932

ZX090

NOMESCO Finland

Other technic of radiotherapy

119.1

229.9

117

A04AD12

ATC

aprepitant; systemic

1152.7

229.4

223

C18.02

ICD-10 Finland

Malignant tumor of caecum carcinoma of adenoma

+∞

225.3

215

C18.10

ICD-10 Finland

Malignant tumor of the appendix without histology

+∞

225.3

215

C18.22

ICD-10 Finland

Malignant tumor of the colon ascending carcinoma of the adenoma

+∞

220.0

210

8140/3-C18.6

ICD-O-3

Adenocarcinoma, NOS, of descending colon

+∞

217.9

208

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

216.8

207

C18.19

ICD-10 Finland

Malignant tumor in appendix other or unspecified histology

+∞

213.7

204

8140/3-C18.3

ICD-O-3

Adenocarcinoma, NOS, of hepatic flexure of colon

+∞

212.6

203

JAH01

NOMESCO Finland

Laparoscopy

5.8

211.0

399

722

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

68.2

208.9

114

TJF80

NOMESCO Finland

Ostomy education

24.5

205.8

146

C18.9

ICD-10 Finland

Malignant neoplasm: Colon, unspecified

+∞

204.2

195

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

4.9

201.9

473

1034

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

409.8

200.2

200

JFB40

NOMESCO Finland

Resection of transverse colon

104.6

199.6

103

C18.50

ICD-10 Finland

Malignant tumor in flexural lienalis without histology

+∞

196.8

188

HAB40

NOMESCO Finland

Wedge excision of mammary gland

18.9

192.6

152

TPH04

NOMESCO Finland

Cathetrisation of vein

2.4

192.4

1740

8577

K56.7

ICD-10 Finland

Ileus, unspecified

7.1

192.0

295

432

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

5.0

190.2

426

896

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

187.4

179

176

Kela drug reimbursment

Regorafenib

+∞

186.3

178

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

9.9

185.1

215

224

Z93.3

ICD-10 Finland

Colostomy status

21.3

179.0

134

C18.91

ICD-10 Finland

Malignant tumor of unspecified location in colon invasive carcinoma

+∞

177.9

170

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

175.8

168

369

Kela drug reimbursment

Regorafenib

+∞

174.7

167

C18.4

ICD-10 Finland

Malignant neoplasm: Transverse colon

+∞

173.7

166

C18

ICD-10 Finland

Malignant neoplasm of colon

+∞

172.6

165

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

6.9

172.6

271

406

L02BA01

ATC

tamoxifen; oral

64.2

172.3

JFB60

NOMESCO Finland

Resection of sigmoid colon with end colostomy

16.1

172.3

147

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

44.6

170.5

101

Z31.5

ICD-10 Finland

Genetic counselling

5.8

169.0

319

575

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

23.9

167.9

120

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

6.9

167.8

263

393

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

15.8

166.9

144

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

1711.6

166.3

161

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.5

165.5

1262

5714

8240/3-C18.1

ICD-O-3

Neuroendocrine tumor, NOS, of appendix

+∞

165.3

158

ZXE10

NOMESCO Finland

More than one and less than three hours

2.1

163.3

2524

15240

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

5.9

163.3

303

537

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

11.6

162.3

168

148

NK6AN

NOMESCO Finland

Total body bone isotope imaging

32.0

160.8

104

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

24.4

159.4

113

UJF30

NOMESCO Finland

Ileoscopy through colon

2.9

159.1

871

3339

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.1

158.2

714

2457

WX600

NOMESCO Finland

Single shot through catheter

14.1

157.0

144

104

8240/3-C18.2

ICD-O-3

Neuroendocrine tumor, NOS, of ascending colon

+∞

156.9

150

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

8.5

155.8

204

248

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

3.3

154.1

616

1969

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

4.0

153.6

464

1230

C18.1

ICD-10 Finland

Malignant neoplasm: Appendix

+∞

149.5

143

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

5.6

149.1

290

537

ZXE30

NOMESCO Finland

More than five and less than seven hours

4.0

147.6

444

1173

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

6.1

145.7

259

440

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

4.2

144.3

401

999

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

362.5

142.4

143

Y77

ICPC

Malignant neoplasm prostate

291.9

139.9

142

WF004

NOMESCO Finland

Palliative radiotherapy

1376.7

138.0

134

8140/3-C18.5

ICD-O-3

Adenocarcinoma, NOS, of splenic flexure of colon

+∞

136.9

131

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

19.6

136.5

106

D70.82

ICD-10 Finland

Drug-induced neutropenia

19.6

136.5

106

D37.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Appendix

31.1

136.4

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

4.6

136.2

337

767

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

+∞

134.8

129

L02BB03

ATC

bicalutamide; oral

+∞

133.8

128

HA1AA

NOMESCO Finland

X-ray mammography

4.9

133.2

300

632

1XC07, ,

NOMESCO Finland

+∞

132.7

127

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

61.5

131.3

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

131.1

2339

14585

A06AH03

ATC

naloxegol; oral

12.8

130.8

127

101

JJB10

NOMESCO Finland

Atypcal resection of liver

1293.7

130.7

127

UJF34

NOMESCO Finland

Left colonoscopy

11.8

130.0

133

115

JFF13

NOMESCO Finland

Terminal enterostomy

29.0

128.9

JWF00

NOMESCO Finland

Reoperation for insufficiency of anastomosis or suture in gastroenterological surgery

36.8

128.7

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

3.6

128.7

442

1278

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

5.6

128.0

248

457

8480/3-C18.0

ICD-O-3

Mucinous adenocarcinoma of cecum

+∞

127.5

122

6404

FHL

Hemicolectomy on the right

36.3

126.6

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

126.4

2192

13504

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

425.7

126.3

126

B01AB04

ATC

dalteparin; parenteral

3.4

125.8

479

1480

8480/3-C18.1

ICD-O-3

Mucinous adenocarcinoma of appendix

+∞

125.4

120

WX704

NOMESCO Finland

Intubation

3.0

125.0

616

2218

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

4.4

124.3

319

747

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

46.1

124.1

JWA00

NOMESCO Finland

Repair of wound dehiscence in gastroenterological surgery

12.7

124.0

121

A02BC02

ATC

pantoprazole; systemic

1.9

122.3

4479

34789

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.4

122.2

948

4280

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

120.1

3219

22653

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.7

120.0

401

1137

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

1179.5

119.2

116

TPX15

NOMESCO Finland

Removal of vascular injection port

27.6

116.4

JFB33

NOMESCO Finland

Other resection comprising small intestine and colon

31.6

115.5

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

114.9

110

KCD02

NOMESCO Finland

Transurethral resection of bladder

11.6

114.6

118

103

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

6.8

113.9

180

271

C18.6

ICD-10 Finland

Malignant neoplasm: Descending colon

+∞

113.9

109

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.4

112.6

924

4267

C18.3

ICD-10 Finland

Malignant neoplasm: Hepatic flexure

+∞

111.8

107

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

111.8

107

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

7.1

111.6

170

246

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

6.0

110.4

198

339

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

283.6

109.3

111

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

43.7

109.1

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

7.6

108.4

155

209

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.5

107.9

764

3298

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

4.6

107.8

261

583

C18.39

ICD-10 Finland

Malignant tumor of flexura hepatica other or unspecified histology

+∞

107.6

103

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

20.5

106.5

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

47.3

104.2

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

103.4

8480/3-C18.2

ICD-O-3

Mucinous adenocarcinoma of ascending colon

+∞

103.4

N02BE01

ATC

paracetamol; systemic, rectal

2.2

101.5

5723

49468

JFB20

NOMESCO Finland

Ileocaecal resection

15.4

100.8

C18.49

ICD-10 Finland

Malignant tumor of the transverse colon other or unspecified histology

+∞

99.2

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

495.2

98.7

JKA20

NOMESCO Finland

Cholecystectomy

3.8

98.5

311

847

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

12.3

98.5

C18.42

ICD-10 Finland

Malignant tumor of the transverse colon carcinoma of the adenoma

+∞

98.1

E0000UV, ,

ATC

1.7

97.6

2601

17933

R4190

NOMESCO Finland

Nutritional therapy

4.9

97.1

219

461

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

325.1

96.2

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

479.7

95.6

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

3.2

95.3

391

1262

JMA10

NOMESCO Finland

Transabdominal total splenectomy

21.1

94.5

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

94.0

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

4.0

93.0

271

697

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

92.9

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

92.9

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

91.9

C18.62

ICD-10 Finland

Malignant tumor of the descending colon carcinoma of the adenoma

+∞

90.8

R4110

NOMESCO Finland

Physiotherapy

1.8

90.1

1758

11017

L01XE21

ATC

[U] regorafenib

+∞

88.7

ZXD05

NOMESCO Finland

Urgent procedure

1.8

88.6

2026

13290

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

23.5

87.6

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

107.1

87.1

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.9

85.7

414

1467

ZX121

NOMESCO Finland

Central venous catheter

34.0

84.9

D77

ICPC

Malignant digestive neopl other/NOS

178.3

84.4

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

4.6

84.1

201

444

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

83.5

C18.5

ICD-10 Finland

Malignant neoplasm: Splenic flexure

+∞

82.4

ZXC96

NOMESCO Finland

Robot assisted procedure

9.4

81.0

105

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

7.7

80.9

114

151

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

80.4

8480/3-C18.7

ICD-O-3

Mucinous adenocarcinoma of sigmoid colon

+∞

80.4

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

4.5

79.7

197

447

K65.0

ICD-10 Finland

Acute peritonitis

5.8

79.1

146

257

ZX080

NOMESCO Finland

Image guided radiotherapy

397.2

79.0

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

11.9

79.0

Z85.0

ICD-10 Finland

Personal history of malignant neoplasm of digestive organs

18.2

78.5

UJG02

NOMESCO Finland

Proctoscopy

4.3

78.1

203

479

V03AF03

ATC

calcium folinate; systemic

767.3

77.5

ZXD10

NOMESCO Finland

Scheduled procedure

1.7

77.5

2377

16742

SPAT1125

SPAT

Stoma care and guidance

4.5

76.9

191

435

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

263.7

76.6

C18.12

ICD-10 Finland

Malignant tumor of the appendix carcinoma of the adenoma

+∞

76.2

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

76.2

C50.99

ICD-10 Finland

Breast, unspecified

381.8

75.9

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

13.2

75.8

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

18.1

75.8

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

4.6

75.7

180

396

R50.9

ICD-10 Finland

Fever, unspecified

2.0

75.4

921

4924

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

8.4

74.4

117

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

12.8

74.2

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

5.9

74.2

134

231

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

74.1

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

74.1

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

24.9

73.9

R18

ICD-10 Finland

Ascites

5.0

73.7

160

326

K92.1

ICD-10 Finland

Melaena

2.5

73.3

494

2071

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

4.4

73.1

189

444

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

716.1

72.3

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

71.4

1264

7620

C18.59

ICD-10 Finland

Malignant tumor in flexura lienalis other or unspecified histology

+∞

70.9

L01EX05

ATC

regorafenib; oral

+∞

70.9

C18.69

ICD-10 Finland

Malignant tumor of colon descendens other or unspecified histology

+∞

70.9

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.6

70.7

452

1848

JFG36

NOMESCO Finland

Closure of terminal colostomy with anastomosis to rectum

26.0

70.6

ZZR00

NOMESCO Finland

Flap of skin

8.2

69.9

115

JG1BG

NOMESCO Finland

MRI of rectum

32.4

69.6

ZX050

NOMESCO Finland

Stereotactic radiotherapy

27.8

69.3

JJB50

NOMESCO Finland

Excision of segments V, VI, VII and VIII of liver

181.9

69.2

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

4.5

68.7

169

382

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

345.8

68.7

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

13.1

68.2

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

4.8

68.1

154

325

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

8.8

67.6

JEA00

NOMESCO Finland

Appendectomy

2.8

67.5

367

1383

L03AA14

ATC

lipegfilgrastim; parenteral

664.9

67.1

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

105.5

67.0

L01BC53

ATC

tegafur, combinations; systemic

+∞

66.8

JJB71

NOMESCO Finland

Laparoscopic resection of liver

+∞

65.7

WX306

NOMESCO Finland

Lumbar epidural anesthesy

2.9

65.7

315

1110

JGB10

NOMESCO Finland

Partial proctectomy and end colostomy

30.9

65.6

SPAT1153

SPAT

Removal of sutures

1.6

65.3

1970

13681

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

64.7

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

634.3

64.0

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

116.2

63.9

JN6AD

NOMESCO Finland

CT of torso and neck

8.1

63.9

108

C18.32

ICD-10 Finland

Malignant tumor of flexura hepatica carcinoma of adenoma

+∞

63.6

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

63.6

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.8

63.1

323

1179

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

17.7

62.8

C18.81

ICD-10 Finland

Malignant overall tumor of the colon invasive carcinoma

+∞

62.6

JN3GE

NOMESCO Finland

Intraoperative ultrasound examination of abdomen

+∞

62.6

JFH10

NOMESCO Finland

Total colectomy and ileostomy

15.5

62.3

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

62.2

3866

31532

JFA42

NOMESCO Finland

Endoscopic injection in colon

9.3

61.8

JEA01

NOMESCO Finland

Laparoscopic appendectomy

3.5

61.8

217

634

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

17.1

61.7

Z93.2

ICD-10 Finland

Ileostomy status

12.0

61.7

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

61.5

JFB53

NOMESCO Finland

Resection of sigmoid colon with partial proctectomy

96.7

60.9

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

603.7

60.8

Z3231

NOMESCO Finland

Registered nurse

1.6

60.4

1668

11293

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

9.3

60.1

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

9.1

59.8

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

17.9

59.3

ZX070

NOMESCO Finland

Intensity modified radiotherapy

156.4

59.0

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

58.4

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

299.8

58.4

C50

ICD-10 Finland

Malignant neoplasm of breast

299.8

58.4

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

57.4

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.4

57.3

406

1738

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

56.3

J01MA12

ATC

levofloxacin; systemic

1.7

56.2

1179

7408

KC1GB

NOMESCO Finland

Cystography with X-ray

18.1

55.9

3AC01, ,

NOMESCO Finland

5.5

55.4

108

200

S18

ICPC

Laceration/cut

1.5

55.4

2731

21001

8140/3-C18.1

ICD-O-3

Adenocarcinoma, NOS, of appendix

+∞

55.3

TQW99

NOMESCO Finland

Other minor procedure on skin

2.8

55.0

279

1013

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

24.5

54.9

JFB51

NOMESCO Finland

Other laparoscopic resection of colon

119.0

54.9

8480/3-C18.9

ICD-O-3

Mucinous adenocarcinoma of colon, NOS

+∞

54.2

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

54.2

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

4.0

53.8

152

382

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

6.3

53.7

144

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

7.3

53.3

108

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

6.3

52.9

143

JFG20

NOMESCO Finland

Closure of enterostomy with resection of exteriorised loop

14.8

52.7

8000/3-C18.9

ICD-O-3

Neoplasm, malignant of colon, NOS

+∞

52.1

JFA58

NOMESCO Finland

Endoscopic dilatation of colon

15.6

52.0

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

4.9

51.6

113

232

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

4.0

51.6

148

376

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

16.6

51.3

Z51.0

ICD-10 Finland

Radiotherapy session

262.6

51.2

8480/3-C18.4

ICD-O-3

Mucinous adenocarcinoma of transverse colon

+∞

51.1

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

51.1

8140/3-C18.8

ICD-O-3

Adenocarcinoma, NOS, of overlapping lesion of colon

+∞

51.1

WX002

NOMESCO Finland

Sedation and analgesia

1.7

50.7

1245

8133

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

4.5

50.5

124

280

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

50.1

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

80.8

49.9

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.2

49.4

195

613

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

491.5

49.4

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

252.0

49.1

C18.80

ICD-10 Finland

Malignant overall tumor of the colon without histology

+∞

49.0

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

171.3

48.9

B80

ICPC

Iron deficiency anaemia

3.3

48.9

186

572

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

10.1

48.6

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.8

48.6

248

903

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

481.3

48.4

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.5

48.3

321

1333

JJB30

NOMESCO Finland

Excision of two segments of liver

246.8

48.1

K35.9

ICD-10 Finland

Acute appendicitis, unspecified

2.4

48.0

361

1585

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

48.0

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

15.9

47.7

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.8

47.6

241

874

LAE10

NOMESCO Finland

Unilateral oophorectomy

12.2

46.1

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

66.7

46.1

SPAT1109

SPAT

Analgesia with portable analgesic pump

8.0

46.0

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

45.9

L02BG03

ATC

anastrozole; oral

161.1

45.9

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

2.7

45.8

255

971

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

44.8

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

4.8

44.7

102

217

D12.7

ICD-10 Finland

Benign neoplasm: Rectosigmoid junction

4.5

44.5

109

246

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.0

44.3

491

2514

JJB60

NOMESCO Finland

Other excsion of three or more segments of liver

440.6

44.3

JJA20

NOMESCO Finland

Open biopsy of liver

13.7

44.2

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

+∞

43.8

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

43.8

C79.6

ICD-10 Finland

Secondary malignant neoplasm of ovary

+∞

43.8

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

43.8

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

3.1

43.7

187

617

ZX112

NOMESCO Finland

Subcutaneous

5.6

43.3

148

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

430.5

43.2

XJA00

NOMESCO Finland

Intraoperative abdominal ultrasonography

430.5

43.2

TJX00

NOMESCO Finland

Punkture or biopsy in gastrointestinal endoscopy

62.9

43.2

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

42.7

C18.52

ICD-10 Finland

Malignant tumor of flexura lienalis carcinoma of adenoma

+∞

42.7

1533A

ICD-9 Finland

Malignant neoplasm of colon, Sigmoid colon[NEOPL MALIG COLI SIGM,INVASIIVINEN KARSINOOMA]

+∞

42.7

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

42.7

128

Kela drug reimbursment

Cancers of female genital organs

420.3

42.2

JFA70

NOMESCO Finland

Suture of small intestine

10.5

41.9

D37.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified

9.3

41.8

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

41.7

C26.0

ICD-10 Finland

Malignant neoplasm: Intestinal tract, part unspecified

+∞

41.7

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

41.7

N02AX02

ATC

tramadol; systemic, rectal

1.4

41.6

2547

20084

WX725

NOMESCO Finland

Noninvasive ventilation

2.3

41.6

327

1463

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.6

41.5

255

1020

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

40.7

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

40.7

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

40.7

R11

ICD-10 Finland

Nausea and vomiting

1.9

40.4

528

2860

Z3226

NOMESCO Finland

Physiotherapist

1.6

40.0

1057

6990

C20

ICD-10 Finland

Malignant neoplasm of rectum

206.2

39.9

JJ6LT

NOMESCO Finland

Coagulation of focal hepatic lesion under ultrasound guidance

206.2

39.9

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

39.6

L02BX02

ATC

degarelix; parenteral

+∞

39.6

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

39.5

699

4157

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.0

39.5

448

2311

K83.1

ICD-10 Finland

Obstruction of bile duct

4.9

39.5

180

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.3

38.9

319

1452

JFC10

NOMESCO Finland

Ileotransversostomy

137.5

38.7

JGB03

NOMESCO Finland

Partial proctectomy with partial excision of mesorectum

137.5

38.7

K56.0

ICD-10 Finland

Paralytic ileus

4.0

38.6

108

270

1534A

ICD-9 Finland

Malignant neoplasm of colon, Caecum[NEOPL MALIG CAECI,INVASIIVINEN KARSINOOMA]

+∞

38.6

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.9

38.3

498

2691

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

4.3

38.3

233

S77

ICPC

Malignant neoplasm of skin

14.1

38.2

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

37.5

ZXE00

NOMESCO Finland

One hour or less

1.4

37.2

2117

16383

K43.2

ICD-10 Finland

Incisional hernia without obstruction or gangrene

7.2

37.2

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

9.4

37.1

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

49.2

36.6

JAQ10

NOMESCO Finland

Intraoperative hypertermic chemotherapeutic perfusion of abdominal cavity

+∞

36.5

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

36.5

D99

ICPC

Disease digestive system other

4.6

36.1

186

Z2221

NOMESCO Finland

Medical doctor

1.5

36.0

1462

10598

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

68.6

36.0

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

9.6

35.9

K91.4

ICD-10 Finland

Colostomy and enterostomy malfunction

12.1

35.9

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

35.9

979

6510

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

186.0

35.8

3049, ,

Kela drug reimbursment

+∞

35.4

8090/3-C44.2

ICD-O-3

Basal cell carcinoma, NOS, of external ear

+∞

35.4

C26.9

ICD-10 Finland

Malignant neoplasm: Ill-defined sites within the digestive system

+∞

35.4

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.9

35.1

456

2462

UKC02

NOMESCO Finland

Cystoscopy

1.6

35.0

1009

6792

L57.0

ICD-10 Finland

Actinic keratosis

1.8

34.9

569

3301

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

6.7

34.8

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

9.2

34.7

178

Kela drug reimbursment

Combination product containing tegafur, gimeracil and oteracil

+∞

34.4

JAL00

NOMESCO Finland

Biopsy of peritoneum

13.4

33.9

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

93.1

33.7

X76

ICPC

Malignant neoplasm breast female

93.1

33.7

J01MA02

ATC

ciprofloxacin; systemic

1.4

33.6

2345

18719

KCD10

NOMESCO Finland

Partial cystectomy

50.3

33.4

8243/3-C18.1

ICD-O-3

Goblet cell carcinoid of appendix

+∞

33.4

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

33.4

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

+∞

33.4

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

33.4

Z43.2

ICD-10 Finland

Attention to ileostomy

44.7

32.7

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.0

32.5

143

480

HAB99

NOMESCO Finland

Other partial excision of mammary gland

5.4

32.5

120

WX882

NOMESCO Finland

High dependency care

2.6

32.4

186

720

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.4

32.4

238

1034

D39.10

ICD-10 Finland

Tumor of uncertain or unknown nature in the ovary without histology

3.4

32.4

116

344

K35.1

ICD-10 Finland

Acute appendicitis with peritoneal abscess

4.2

32.4

207

JWW96

NOMESCO Finland

Other reoperation in gastroenterological surgery

12.4

32.4

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

+∞

32.3

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

+∞

32.3

JJB20

NOMESCO Finland

Excision of single segment of liver

+∞

32.3

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

32.3

C18.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of colon

+∞

32.3

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

32.3

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

32.3

GD1AD

NOMESCO Finland

Thorax CT examination

2.1

32.3

310

1503

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

8.6

32.2

JFK10

NOMESCO Finland

Freeing of adhesions in intestinal obstruction

6.9

32.2

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

3.7

32.1

103

284

LCD00

NOMESCO Finland

Hysterectomy

2.4

32.0

217

910

8480/1-C18.1

ICD-O-3

Low grade appendiceal mucinous neoplasm of appendix

318.6

31.9

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

318.6

31.9

H01CB03

ATC

lanreotide; parenteral

72.5

31.9

ZX100

NOMESCO Finland

Oral

3.7

31.7

268

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

3.3

31.4

116

351

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

31.3

8480/3-C18.3

ICD-O-3

Mucinous adenocarcinoma of hepatic flexure of colon

+∞

31.3

L01EC03

ATC

encorafenib; oral

+∞

31.3

1XC08, ,

NOMESCO Finland

+∞

31.3

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

314.3

30.8

L02AE04

ATC

triptorelin; parenteral

160.7

30.7

TKE00

NOMESCO Finland

Needle biopsy of prostate

2.5

30.6

189

759

ZXC40

NOMESCO Finland

Use of ultrasound

7.0

30.5

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

30.3

440

2460

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

3.4

30.3

109

324

E34.0

ICD-10 Finland

Carcinoid syndrome

51.7

30.3

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

+∞

30.2

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

30.2

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

38.2

30.2

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

5.0

30.2

132

WGA11

NOMESCO Finland

Planning of pain management

8.3

29.9

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.3

29.7

224

984

JN4DD

NOMESCO Finland

Scout CT scan of torso

155.7

29.7

D48.42

ICD-10 Finland

Tumor of uncertain or unknown nature in the peritoneum originating in the appendix

155.7

29.7

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

155.7

29.7

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

107.2

29.7

WX892

NOMESCO Finland

Monitored bed care

1.8

29.6

476

2746

SPAT1255

SPAT

Intravenous administration of medicine

1.8

29.6

430

2406

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.7

29.5

564

3417

ZXC20

NOMESCO Finland

Use of chemical agents

3.3

29.3

109

331

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

11.1

29.3

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

29.2

8210/3-C18.7

ICD-O-3

Adenocarcinoma in adenomatous polyp of sigmoid colon

+∞

29.2

L02BB04

ATC

enzalutamide; oral

+∞

29.2

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

29.2

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

29.2

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.1

29.0

297

1476

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

3.5

28.7

287

JAD10

NOMESCO Finland

Repair of incisional hernia

4.6

28.4

147

D64.8

ICD-10 Finland

Other specified anaemias

2.8

28.3

139

497

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.3

28.2

108

334

P01AB01

ATC

metronidazole; oral, rectal

1.4

28.2

2048

16339

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

28.1

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

28.1

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

3.6

28.0

258

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

4.2

27.9

174

L02BG06

ATC

exemestane; oral

282.7

27.8

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

282.7

27.8

C17.2

ICD-10 Finland

Malignant neoplasm: Ileum

282.7

27.8

JFF11

NOMESCO Finland

Laparoscopic loop enterostomy

42.7

27.7

H01CB02

ATC

octreotide; parenteral

42.7

27.7

9707

FHL

Ablation of mammae and removal of axillary lymph nodes

145.6

27.6

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

27.1

1526, ,

Kela drug reimbursment

+∞

27.1

Y83.2

ICD-10 Finland

Surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

7.0

27.1

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

8.4

27.0

D50

ICD-10 Finland

Iron deficiency anaemia

2.8

26.7

136

496

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

140.6

26.6

LAF16

NOMESCO Finland

Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

140.6

26.6

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

8.5

26.6

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

8.5

26.6

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.9

26.4

128

454

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

26.1

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

26.1

C18.89

ICD-10 Finland

Malignant overall tumor of the colon other or unspecified histology

+∞

26.1

YJ1AD

NOMESCO Finland

CT examination of abdomen for dose design of radiotherapy

60.2

26.0

Y83.6

ICD-10 Finland

Removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

9.7

25.9

B82

ICPC

Anaemia other/unspecified

2.3

25.8

199

883

L02AE03

ATC

goserelin; implant

8.5

25.7

D01.0

ICD-10 Finland

Carcinoma in situ: Colon

93.8

25.6

JK3BT

NOMESCO Finland

Catherisation of bile duct with X-ray guidance

10.0

25.6

WX290

NOMESCO Finland

Other blockage of nerve

1.4

25.5

1962

15739

WPB10

NOMESCO Finland

Making a convalescent care decision

10.4

25.3

KAC10

NOMESCO Finland

Total nephrectomy with capsule

25.1

25.2

Z93

ICD-10 Finland

Artificial opening status

25.1

25.2

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

4.0

25.2

179

C82.1

ICD-10 Finland

Follicular lymphoma grade II

+∞

25.0

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

25.0

L01CB01

ATC

etoposide; systemic

+∞

25.0

1536A

ICD-9 Finland

Malignant neoplasm of colon, Ascending colon[NEOPL MALIG COLI ASCENDENTIS,INVASIIVINEN KARSINOOM]

+∞

25.0

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

8.5

24.9

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

70.1

24.8

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

24.7

673

4448

KBV10

NOMESCO Finland

Removal of stent from ureter

4.8

24.7

115

6434

FHL

Anterior resection

23.4

24.7

JFF30

NOMESCO Finland

Other colostomy

21.3

24.7

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

130.5

24.6

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

32.1

24.6

Z51.4

ICD-10 Finland

Preparatory care for subsequent treatment, not elsewhere classified

3.5

24.5

238

Z43.3

ICD-10 Finland

Attention to colostomy

27.6

24.4

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.6

24.4

136

520

JN5ER

NOMESCO Finland

PET-CT of receptors in whole body

20.1

24.3

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

2.9

24.2

113

393

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

24.2

908

6428

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

3.3

24.1

270

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

24.0

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.8

23.9

353

1983

J01DB01

ATC

cefalexin; oral

1.3

23.8

4690

42759

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

87.1

23.6

JN7AQ

NOMESCO Finland

Somatostatin receptor SPET med low dose CT

240.8

23.6

SPAT1131

SPAT

Colonoscopy

2.1

23.6

214

1015

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.1

23.6

228

1109

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

23.4

1209

9071

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

9.7

23.2

ZXC15

NOMESCO Finland

Use of photodynamic technique

3.8

23.2

181

SPAT1088

SPAT

Blood transfusion

5.2

23.1

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

23.0

963

6955

ZQZ00

NOMESCO Finland

Treatment of several skin areas

9.1

22.9

8244/3-C18.1

ICD-O-3

Mixed adenoneuroendocrine carcinoma of appendix

+∞

22.9

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

22.9

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

+∞

22.9

C18.82

ICD-10 Finland

Malignant overall tumor of colon carcinoma of adenoma

+∞

22.9

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.5

22.9

139

554

D50.8

ICD-10 Finland

Other iron deficiency anaemias

2.9

22.8

105

363

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

3.6

22.7

207

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

4.1

22.7

153

JFH96

NOMESCO Finland

Other total colectomy

40.2

22.6

KAD00

NOMESCO Finland

Partial nephrectomy

9.3

22.6

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

25.9

22.6

JGB30

NOMESCO Finland

Abdominoperineal excision of rectum

120.4

22.6

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

22.5

646

4318

XKD00

NOMESCO Finland

Uroflowmetry

1.5

22.3

914

6573

WX004

NOMESCO Finland

Patient-controlled sedation

4.9

22.2

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.9

22.2

282

1511

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

3.5

22.0

211

L01BC04

ATC

carmofur; oral

+∞

21.9

PC2ET

NOMESCO Finland

Extensive embolisation of lesion of liver

+∞

21.9

WB402

NOMESCO Finland

Demanding antibody therapy of primary tumour

+∞

21.9

D12.1

ICD-10 Finland

Benign neoplasm: Appendix

6.2

21.9

A06AD11

ATC

lactulose; oral

1.4

21.9

1001

7346

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

62.7

21.8

TJA10

NOMESCO Finland

Laparocentesis

29.1

21.8

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

3.3

21.6

248

JWE00

NOMESCO Finland

Reoperation for deep haemorrhage in gastroenterological surgery

6.9

21.6

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

220.7

21.6

C90.0

ICD-10 Finland

Multiple myeloma

115.4

21.6

B03XA02

ATC

darbepoetin alfa; parenteral

2.7

21.3

114

427

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

2.8

21.1

102

362

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

50.2

21.1

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

4.2

21.1

131

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

3.6

21.1

189

UJK02

NOMESCO Finland

ERCP

2.3

21.1

161

713

JFB63

NOMESCO Finland

Other resection of colon with proximal colostomy and closure of distal stump

28.1

20.9

TQW20

NOMESCO Finland

Tatoe

28.1

20.9

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

20.8

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

20.8

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

+∞

20.8

DAB10

NOMESCO Finland

Partial excision of auricle

37.3

20.7

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.1

20.7

202

987

D48.49

ICD-10 Finland

Tumor of uncertain or unknown nature in the peritoneum, of unknown origin

77.0

20.7

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

210.6

20.6

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

110.4

20.6

KH1AA

NOMESCO Finland

Urinary tract X-ray examination without contrast

3.2

20.5

256

KA1FN

NOMESCO Finland

Isotope renography

5.5

20.5

LAF00

NOMESCO Finland

Unilateral salpingo-oophorectomy

4.1

20.5

134

WPA16

NOMESCO Finland

Extensive demanding palliative symptom assessment and treatment

41.8

20.4

XQ902

NOMESCO Finland

Other photography

4.6

20.3

106

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

20.2

322

1851

JGB04

NOMESCO Finland

Laparoscopic partial proctectomy with partial excision of mesorectum

48.1

20.1

Z2446

NOMESCO Finland

Social worker

1.8

20.1

292

1634

G62.0

ICD-10 Finland

Drug-induced polyneuropathy

17.3

20.0

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

57.7

19.9

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.4

19.8

131

544

C83.1

ICD-10 Finland

Mantle cell lymphoma

+∞

19.8

352

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

19.8

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

+∞

19.8

L02BX03

ATC

abiraterone; oral

+∞

19.8

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

+∞

19.8

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

+∞

19.8

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

19.8

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

2.9

19.8

331

C44.10

ICD-10 Finland

Malignant tumor of the skin of the eyelids including the corner of the eye without histology

105.3

19.6

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

200.5

19.6

XX1AD

NOMESCO Finland

Other CT-examination

40.2

19.5

D04.4

ICD-10 Finland

Carcinoma in situ: Skin of scalp and neck

5.0

19.5

WW200, ,

SPAT

0.7

19.3

724

10017

WX610

NOMESCO Finland

Patient controlled analgesia

5.5

19.3

WZA10

NOMESCO Finland

Extensive medical or dental certificate

3.4

19.2

201

JFB41

NOMESCO Finland

Laparoscopic resection of transverse colon

46.1

19.2

JFF26

NOMESCO Finland

Sigmoidostomy

16.7

19.1

G04BE03

ATC

sildenafil; oral

4.6

19.1

GDB21

NOMESCO Finland

Thoracoscopic segmental resection of lung

26.1

19.1

SPAT1262

SPAT

Handing over of treatment supplies

1.4

19.0

1056

7998

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

2.6

18.9

105

401

JFC20

NOMESCO Finland

Other enterocolostomy

34.4

18.9

JF2BD

NOMESCO Finland

Extensive colon CT

3.2

18.8

234

C80.99

ICD-10 Finland

Malignant tumor without specified localization or histology

+∞

18.8

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

18.8

JJB40

NOMESCO Finland

Excision of segments II, III and IV of liver

+∞

18.8

15302

ICD-8 Finland

Malignant neoplasm of large intestine, except rectum, Cacci

+∞

18.8

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

+∞

18.8

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

18.8

L01CA04

ATC

vinorelbine; systemic

+∞

18.8

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

+∞

18.8

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

18.8

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

+∞

18.8

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

18.8

C77.5

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes

+∞

18.8

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

18.8

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

70.1

18.7

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

70.1

18.7

ZXC50

NOMESCO Finland

Cryotherapy

2.3

18.6

137

598

QXE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in uspecified region

6.1

18.5

XX1XN

NOMESCO Finland

Other isotope examination

190.5

18.5

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

190.5

18.5

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.9

18.4

219

1148

C10AA07

ATC

rosuvastatin; oral

0.7

18.4

1247

15694

DHB00

NOMESCO Finland

Excision of lesion of external nose

6.2

18.4

C10AX09

ATC

ezetimibe; oral

0.7

18.3

513

7511

JFB96

NOMESCO Finland

Other partial excision of intestine

25.1

18.2

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

18.2

845

6204

D23.3

ICD-10 Finland

Benign neoplasm: Skin of other and unspecified parts of face

2.4

18.0

128

550

JGA05

NOMESCO Finland

Endoscopic polypectomy in rectum

3.8

17.9

139

KCH00

NOMESCO Finland

Suture of bladder

6.9

17.8

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

26.7

17.8

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

+∞

17.7

8480/3-C18.6

ICD-O-3

Mucinous adenocarcinoma of descending colon

+∞

17.7

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

17.7

C65

ICD-10 Finland

Malignant neoplasm of renal pelvis

+∞

17.7

XX7JT

NOMESCO Finland

Somatostatin isotope ablative therapy

+∞

17.7

9680/3-C18.0

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of cecum

+∞

17.7

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

+∞

17.7

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

+∞

17.7

QX9VV, ,

NOMESCO Finland

66.8

17.7

TQW40

NOMESCO Finland

Remowal of suture of skin

1.7

17.6

318

1894

KA3EB

NOMESCO Finland

Antegrade pyelography

6.1

17.6

2390A

ICD-9 Finland

Neoplasm of unspecified nature, Digestive system

5.4

17.6

JJ7LT

NOMESCO Finland

Coagulation of focal hepatic lesion under CT guidance

180.4

17.5

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

0.7

17.1

951

12349

JG1CG

NOMESCO Finland

Extensive MRI of rectum

14.8

17.1

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

50.1

17.0

JGB07

NOMESCO Finland

Laparoscopic partial proctectomy with total excision of mesorectum

50.1

17.0

C44.22

ICD-10 Finland

Spinocellular carcinoma of the skin of the outer ear and the outer ear canal

50.1

17.0

R10.0

ICD-10 Finland

Acute abdomen

2.1

16.9

166

813

JFB21

NOMESCO Finland

Laparoscopic ileocaecal resection

13.2

16.9

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

16.9

726

5252

KEB00

NOMESCO Finland

Biopsy of prostate

4.0

16.9

118

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.0

16.8

181

918

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.7

16.8

350

UJF32, ,

SPAT

2.1

16.8

150

710

K62.7

ICD-10 Finland

Radiation proctitis

+∞

16.7

KCC10

NOMESCO Finland

Cystoprostatectomy

+∞

16.7

1CD02, ,

NOMESCO Finland

+∞

16.7

JJA40

NOMESCO Finland

Excision of lesion of liver

+∞

16.7

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

+∞

16.7

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

+∞

16.7

8240/3-C18.0

ICD-O-3

Neuroendocrine tumor, NOS, of cecum

+∞

16.7

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

16.7

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

16.7

8070/3-C44.6

ICD-O-3

Squamous cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

16.7

A41.9

ICD-10 Finland

Sepsis, unspecified

1.9

16.6

217

1174

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

15.0

16.6

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

170.4

16.5

JJB53

NOMESCO Finland

Excision of segments IV,V, VI, VII and VIII of liver

170.4

16.5

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

170.4

16.5

N02AA01

ATC

morphine; systemic, rectal

2.6

16.4

348

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

40.2

16.3

D16

ICPC

Rectal bleeding

2.2

16.3

129

581

D01

ICPC

Abdominal pain/cramps general

1.5

16.2

513

3497

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

4.6

16.1

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

16.0

1500

12220

JFH01

NOMESCO Finland

Laparoscopic colectomy with ileorectal anastomosis

47.6

16.0

D06BX01

ATC

metronidazole; topical

1.5

16.0

486

3285

C44.52

ICD-10 Finland

Spinocellular carcinoma of the skin on the torso

18.5

16.0

KBV00

NOMESCO Finland

Insertion of stent into ureter

4.4

15.9

N05AX08

ATC

risperidone; systemic

0.6

15.8

244

4115

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

3.2

15.8

186

JFK00

NOMESCO Finland

Division of adhesive band in intestinal obstruction

5.9

15.7

JAG60

NOMESCO Finland

Reconstruction of abdominal wall using prosthetic material

6.9

15.7

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

15.6

C56.98

ICD-10 Finland

Malignant tumor of the ovary, indeterminate histology

+∞

15.6

C79.7

ICD-10 Finland

Secondary malignant neoplasm of adrenal gland

+∞

15.6

C17.0

ICD-10 Finland

Malignant neoplasm: Duodenum

+∞

15.6

8000/3-C25.9

ICD-O-3

Neoplasm, malignant of pancreas, NOS

+∞

15.6

8130/3-C67.9

ICD-O-3

Papillary urothelial carcinoma of bladder, NOS

+∞

15.6

C80.90

ICD-10 Finland

Malignant tumor without specified localization without histology

+∞

15.6

8000/3-C18.7

ICD-O-3

Neoplasm, malignant of sigmoid colon

+∞

15.6

WB600

NOMESCO Finland

Neoadjuvant therapy of primary tumour with antibodies

+∞

15.6

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

15.6

WF090

NOMESCO Finland

Profylactic radiotherapy

+∞

15.6

L01AX03

ATC

temozolomide; systemic

+∞

15.6

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.7

15.6

316

1943

JFF24

NOMESCO Finland

Laparoscopic transversostomy

85.3

15.6

JA3CT

NOMESCO Finland

Cathetrisation of abdominal cavity with CT guidance

22.1

15.5

R86.0

ICD-10 Finland

Abnormal findings in specimens from male genital organs, abnormal level of enzymes

2.7

15.5

301

ZXF99

NOMESCO Finland

Other r3eason to interrupt procedure

5.1

15.5

WPA13

NOMESCO Finland

Palliative consultation

6.4

15.4

K63.5

ICD-10 Finland

Polyp of colon

2.2

15.3

121

545

KE1BG

NOMESCO Finland

MRI of prostate

5.9

15.2

K59.09

ICD-10 Finland

Constipation, unspecified

1.6

15.2

399

2611

KCD32

NOMESCO Finland

Cystoscopic destruction of tumour of bladder

4.3

15.2

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

6.1

15.1

JFG26

NOMESCO Finland

Closure of terminal enterostomy with anastomosis to colon

23.4

15.1

JK4ZT

NOMESCO Finland

Percutaneous transhepatic implantation of bile duct prothesis

45.1

15.0

Y69

ICD-10 Finland

Unspecified misadventure during surgical and medical care

2.9

15.0

245

GDC00

NOMESCO Finland

Lobectomy of lung

13.9

15.0

XJH00

NOMESCO Finland

Transanal ultrasonography

1.6

14.9

331

2081

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.0

14.8

153

765

N06DX01

ATC

memantine; oral

0.6

14.8

304

4777

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.3

14.8

1200

9581

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

5.9

14.8

KH1CD

NOMESCO Finland

Very extensive urinary tract ultrasound examination

3.4

14.7

159

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.7

14.7

864

11154

C44.42

ICD-10 Finland

Spinocellular carcinoma of the skin of the scalp and neck

25.1

14.7

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

3.1

14.6

195

XX3AT

NOMESCO Finland

Other labeling with ultrasound guidance

21.1

14.6

WB223

NOMESCO Finland

Demanding adjuvant hormone therapy of malignancy

+∞

14.6

C80.92

ICD-10 Finland

Malignant tumor without specified localization adenocarcinoma

+∞

14.6

8000/3-C18.2

ICD-O-3

Neoplasm, malignant of ascending colon

+∞

14.6

8480/3-C18.8

ICD-O-3

Mucinous adenocarcinoma of overlapping lesion of colon

+∞

14.6

8249/3-C18.0

ICD-O-3

Neuroendocrine tumor, grade 2 of cecum

+∞

14.6

C32.0

ICD-10 Finland

Malignant neoplasm: Glottis

+∞

14.6

C50.19

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, other or undeterminated histology

+∞

14.6

ZXA00

NOMESCO Finland

Right side

1.3

14.6

1502

12365

C43.62

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type

80.3

14.6

Z08.1

ICD-10 Finland

Follow-up examination after radiotherapy for malignant neoplasm

80.3

14.6

C76.2

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Abdomen

150.3

14.5

C54.1

ICD-10 Finland

Malignant neoplasm: Endometrium

150.3

14.5

U76

ICPC

Malignant neoplasm of bladder

150.3

14.5

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

14.4

805

6083

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

3.5

14.4

142

RD211, ,

NOMESCO Finland

1.8

14.3

211

1188

QBE15

NOMESCO Finland

Excision of other superficial lesion of skin of trunk

5.5

14.3

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.3

14.2

106

466

JFG29

NOMESCO Finland

Closure of terminal enterostomy with anastomosis to rectum

19.1

14.2

JAA10

NOMESCO Finland

Excision of lesion of abdominal wall

22.3

14.2

A28

ICPC

Limited function/disability NOS

1.3

14.2

1171

9367

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.2

14.1

113

513

JN2AE

NOMESCO Finland

Ultrasound examination of lower part of abdomen without contrast

3.0

14.1

205

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

2.2

13.9

115

529

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

13.8

1769

14930

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

4.6

13.7

CBB50

NOMESCO Finland

Excision of lesion of eyelid and reconstruction using graft or flap

75.3

13.6

KFC10

NOMESCO Finland

Bilateral orchiectomy

75.3

13.6

3054, ,

Kela drug reimbursment

+∞

13.5

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

+∞

13.5

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

+∞

13.5

1XA03, ,

NOMESCO Finland

+∞

13.5

1523, ,

Kela drug reimbursment

+∞

13.5

C67.0

ICD-10 Finland

Malignant neoplasm: Trigone of bladder

+∞

13.5

XX9AN

NOMESCO Finland

Complementary isotope examination or additional picture

34.1

13.5

C44.50

ICD-10 Finland

Malignant tumor of the skin on the torso without histology

34.1

13.5

XF600

NOMESCO Finland

Bloodpressure measurement

1.6

13.5

334

2158

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

2.7

13.5

260

B02AA02

ATC

tranexamic acid; systemic

1.4

13.4

523

3715

JKE25

NOMESCO Finland

Endoscopic external drainage of bile duct

12.8

13.4

C187, 8211, 2

ICD-O-3

21.2

13.3

I25.1

ICD-10 Finland

Atherosclerotic heart disease

0.8

13.3

1261

15303

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

4.8

13.3

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

10.4

13.2

NK6LA

NOMESCO Finland

Bone and joint kinetic X-ray examination

5.7

13.2

JF2AB

NOMESCO Finland

Colongraphy with X-ray

9.7

13.2

A21

ICPC

Risk factor for malignancy

40.1

13.1

R52.0

ICD-10 Finland

Acute pain

2.0

13.1

136

682

D70.89

ICD-10 Finland

Neutropenic splenomegaly

3.3

13.1

141

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

12.1

13.1

D07AA02

ATC

hydrocortisone; topical

1.4

13.0

638

4717

Z80.8

ICD-10 Finland

Family history of malignant neoplasm of other organs or systems

10.9

13.0

C44.3

ICD-10 Finland

Malignant neoplasm: Skin of other and unspecified parts of face

28.4

12.9

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

2.0

12.9

140

713

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

2.6

12.7

285

JLC10

NOMESCO Finland

Distal pancreatectomy

14.0

12.7

KH1YT

NOMESCO Finland

Percutaneous implantation of endoprothesis with radiological guidance

10.5

12.7

JFA45

NOMESCO Finland

Endoscopic contact coagulation in colon

3.8

12.7

101

WVA20

NOMESCO Finland

Medicine administration

2.1

12.6

119

576

D74

ICPC

Malignant neoplasm stomach

70.0

12.6

6407

FHL

Colectomy and ileorectostomy

70.0

12.6

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3002256) Pathology report gross observation

1144

3484

3.76

318.45

1.4

1.1

—

(3023368) Bacteria identified in Blood by Culture

2841

14562

2.68

316.46

4.9

3.9

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1534

975

20.22

307.65

5.6

1.8

1948.47

19.64

u/ml

2.85

1379

775

(3024561) Albumin [Mass/volume] in Serum or Plasma

4216

21701

3.63

307.65

9.3

3.7

33.41

35.20

g/l

67.74

4068

19686

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

4729

2678

60.51

307.65

8.8

1.4

39.43

2.74

ug/l

10.36

4368

1984

(3044640) Blood type and Crossmatch panel - Blood

3310

14251

3.67

307.65

3.1

2.2

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1991

7700

3.27

307.65

2.2

2.6

2.44

2.29

g/l

21.51

1912

7013

(3022145) Colonoscopy Study observation

2354

4821

7.05

307.65

1.4

1.3

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

4275

26165

2.82

307.65

15.7

6.1

4.04

4.42

e9/l

18.78

3794

22257

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1568

3661

5.31

307.65

2.5

1.9

0.20

g/l

0.02

1507

3282

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1921

7234

3.34

307.65

2.2

2.7

17.44

21.97

33.39

1714

5996

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2776

13930

2.72

307.65

2.4

2.3

4.06

2.98

mg/l

43.39

2444

11724

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2634

10829

3.39

307.65

2.9

2.2

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4602

24426

3.95

307.65

13.9

3.7

11.93

12.17

umol/l

0.53

4495

22764

(4035726) Immunohistochemistry procedure

1530

1197

16.36

307.65

1.4

1.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4176

21177

3.67

307.65

3.4

2.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

783

567

15.54

307.65

5.4

1.8

243.69

19.82

u/ml

4.80

714

508

(3033658) Prothrombin time (PT) actual/Normal

2481

11641

2.82

307.65

5.4

3.5

86.37

84.83

2.13

2449

11319

(40768804) Tissue Pathology biopsy report

3235

14909

3.30

307.65

2.6

1.6

—

(3022948) Iron [Moles/volume] in Serum or Plasma

2081

8393

3.16

307.65

2.3

2.5

10.41

12.48

umol/l

23.75

1989

7662

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

265

222

12.39

265.02

4.2

1.6

7.03

4.67

nmol/l

0.43

259

211

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

315

354

9.29

256.68

2.1

1.7

304.33

14.93

u/ml

0.76

309

346

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5231

38050

2.84

255.68

15.3

5.3

94.41

76.28

u/l

48.03

5078

35018

(3022217) INR in Platelet poor plasma by Coagulation assay

4038

26123

2.42

252.46

16.7

19.6

1.29

1.38

inr

6.07

1130

7199

(3037121) Protein [Mass/volume] in Urine

672

1671

4.37

245.19

5.7

2.5

0.18

0.33

g/l

9.95

509

563

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2837

15898

2.38

244.66

3.0

2.3

57.07

60.08

u/l

0.83

2712

14505

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1266

4977

2.91

225.92

3.2

2.1

10.25

7.91

umol/l

2.25

1145

4226

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3239

19790

2.26

220.99

3.1

2.9

112.64

136.25

ug/l

6.33

3004

17911

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3910

26319

2.20

203.00

8.3

5.7

1.20

1.21

mmol/l

30.01

3372

22114

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

142

25.00

201.87

2.0

1.1

18.11

16.11

u/ml

0.65

137

(3015377) Calcium [Moles/volume] in Serum or Plasma

2762

16458

2.17

193.03

7.7

2.1

2.35

mmol/l

0.56

2530

13685

(3013826) Glucose [Moles/volume] in Serum or Plasma

4321

30632

2.20

191.63

6.2

4.5

6.91

6.90

mmol/l

0.06

4156

28606

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1589

7533

2.46

191.49

4.9

2.4

0.80

0.82

mmol/l

10.88

1519

6844

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

812

2720

3.26

189.60

8.5

9.6

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

983

3684

2.96

189.04

1.6

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1881

9774

2.30

182.61

8.6

2.2

2.48

2.45

mmol/l

17.39

1773

8304

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3565

23803

2.09

180.50

7.4

5.3

1.20

1.21

mmol/l

18.27

3341

21095

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1029

4103

2.79

175.51

2.7

2.2

39.00

37.54

u/l

0.14

922

3448

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1165

5073

2.58

165.99

8.0

7.5

113.71

122.15

g/l

39.83

1141

4937

(3016502) Oxygen saturation in Arterial blood

1246

5671

2.48

161.20

7.6

7.0

96.46

95.03

12.04

1217

5451

(3003694) ABO and Rh group [Type] in Blood

1973

11128

2.10

151.03

1.4

1.3

—

(3003396) Base excess in Arterial blood by calculation

1310

6264

2.36

150.86

7.4

6.7

0.49

1.35

mmol/l

11.67

1070

4903

(3027801) Oxygen [Partial pressure] in Arterial blood

1311

6283

2.36

150.12

7.5

6.7

13.87

11.38

kpa

44.42

1269

5952

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1311

6288

2.35

149.82

7.5

6.7

5.12

5.04

kpa

2.69

1271

5972

(3014111) Lactate [Moles/volume] in Serum or Plasma

1054

4610

2.53

147.45

6.5

6.3

1.29

1.43

mmol/l

3.75

1031

4469

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

559

1764

3.37

142.42

2.4

2.9

0.32

0.35

u/ml

1.16

323

1037

(40768441) Liver Pathology biopsy report

156

152

10.49

140.74

1.1

1.3

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

455

1264

3.79

140.71

2.7

1.5

61.54

26.35

u/ml

3.62

445

1179

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

33.39

139.34

2.5

1.0

45.28

19.35

u/ml

0.65

(3000991) Gas panel - Venous blood

984

4309

2.51

136.58

7.4

7.6

—

(40758558) Short blood count panel - Blood

1915

11019

2.04

136.42

12.3

4.6

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2315

14499

1.92

127.19

4.8

2.6

40.90

34.62

u/l

0.74

2210

13551

(3019069) Monocytes/100 leukocytes in Blood

3181

22152

1.84

124.34

5.4

5.8

9.02

8.80

2.90

2968

20330

(3006504) Eosinophils/100 leukocytes in Blood

3166

22039

1.84

123.68

5.1

5.5

2.68

2.96

8.51

2957

20185

(3002030) Lymphocytes/100 leukocytes in Blood

3229

22625

1.84

123.39

5.3

5.6

23.98

26.54

30.30

3024

20820

(3022096) Basophils/100 leukocytes in Blood

3082

21359

1.83

121.39

5.2

5.5

0.60

0.66

10.10

2876

19541

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1073

5153

2.29

119.87

3.1

2.5

243.89

241.90

u/l

0.17

1020

4728

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

679

2647

2.75

118.57

8.4

8.8

23.88

24.46

mmol/l

5.02

670

2521

(3027945) Reticulocytes/100 erythrocytes in Blood

1240

6369

2.17

117.20

1.9

2.0

1.85

1.77

1.58

1097

5481

(3020779) Urea [Moles/volume] in Serum or Plasma

1001

4727

2.32

116.07

5.7

6.6

9.66

11.47

mmol/l

11.09

954

4426

(3002582) Erythrocytes [#/volume] in Urine

2390

15478

1.85

115.73

3.5

3.1

48.18

97.63

e6/l

2.76

1890

11837

(3042936) Bacteria identified in Isolate by Culture

1309

6913

2.12

114.89

2.1

2.0

—

(40760892) CBC W Ordered Manual Differential panel - Blood

3119

21999

1.80

113.15

5.4

5.6

—

(3018010) Neutrophils/100 leukocytes in Blood

3156

22365

1.79

112.43

5.2

5.5

60.24

58.36

13.17

2964

20581

(3006315) Basophils [#/volume] in Blood

3301

23843

1.77

108.88

4.8

5.2

0.04

e9/l

4.94

2771

20287

(3001604) Monocytes [#/volume] in Blood

3284

23740

1.77

107.50

4.8

5.2

0.63

0.62

e9/l

3.25

2752

20198

(3019198) Lymphocytes [#/volume] in Blood

3345

24391

1.76

105.48

5.0

5.3

1.78

1.82

e9/l

0.22

2884

21185

(3013115) Eosinophils [#/volume] in Blood

3363

24644

1.75

103.43

5.0

5.4

0.19

0.21

e9/l

6.88

2866

21229

(3030467) Casts [#/volume] in Urine by Automated count

2173

14213

1.79

98.04

3.4

3.1

0.62

0.48

e6/l

1.07

1705

10816

(3031040) Bacteria [#/volume] in Urine by Automated count

4260

33739

1.75

95.81

4.9

4.7

2082.02

2035.66

e6/l

0.01

566

(4281824) Cell count and differential, peritoneal fluid

146

221

6.73

91.87

1.1

1.2

—

(36304419) Bacteria [Presence] in Urine

2070

13619

1.76

89.83

3.4

3.0

—

(3018095) Leukocytes [#/volume] in Urine

2568

17972

1.70

88.94

4.1

3.6

95.76

123.73

e6/l

1.19

1958

12713

(3026782) Osmolality of Urine

1671

10376

1.82

87.96

3.3

2.9

544.97

540.45

mosm/kgh2o

0.35

1472

8747

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

340

1071

3.29

86.10

1.9

2.3

3.72

3.60

g/l

0.68

332

1006

(3023520) Reticulocytes [#/volume] in Blood

922

4754

2.09

83.94

2.0

2.1

70.27

68.51

e9/l

0.68

707

3615

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

635

2866

2.35

80.21

7.1

24.42

24.86

mmol/l

2.22

629

2830

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1162

6604

1.92

79.97

5.0

5.2

1.02

1.04

mmol/l

1.49

1083

6001

(3018418) pH of Serum or Plasma

2223

15306

1.68

79.59

4.7

3.3

7.39

7.40

2.89

458

2640

(40768795) Lymph node Pathology biopsy report

11.77

76.46

1.2

1.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1321

8033

1.81

72.62

3.2

2.8

2.83

2.59

e6/l

0.38

762

4396

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

506

2162

2.45

72.03

2.0

1.8

1.47

1.95

ug/l

1.07

452

1851

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3698

29427

1.59

70.20

3.8

3.0

73.31

49.19

u/l

18.64

3472

26600

(3000850) Epithelial cells [#/volume] in Urine

1647

10887

1.68

66.48

2.7

2.6

5.54

4.83

e6/l

1.64

1497

9633

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

304

1044

3.00

66.35

1.9

2.3

218.35

194.87

4.25

293

985

(3026008) Bacteria identified in Urine by Culture

2337

16878

1.60

66.04

3.3

3.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

402

1605

2.60

65.91

1.4

1.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

315

1120

2.90

64.58

1.9

2.0

82.02

90.04

6.97

310

1065

(40768797) Stomach Pathology biopsy report

1132

6841

1.79

62.54

1.2

—

(40768800) Prostate Pathology biopsy report

129

254

5.16

61.83

1.1

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

5552

49526

1.78

60.65

28.0

14.5

37.72

24.74

mg/l

107.59

5178

39229

(3037467) Urinalysis macro (dipstick) panel - Urine

4205

35111

1.55

59.45

5.4

4.5

—

(40768793) Breast Pathology biopsy report

115

213

5.48

59.00

1.3

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

13.95

58.70

1.2

1.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1385

9060

1.67

56.88

1.9

1.8

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1270

8242

1.67

53.36

2.0

1.9

30.01

30.06

0.10

1242

7985

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1325

8798

1.63

50.55

3.1

2.6

1.29

1.20

e6/l

0.33

759

5128

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

193

602

3.27

49.56

1.3

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

489

2415

2.11

48.75

6.0

4.9

0.88

0.87

0.22

462

2276

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

492

2443

2.10

48.35

5.8

4.9

1.55

1.62

0.97

466

2302

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

511

2600

2.05

46.98

1.4

1.5

1.76

1.55

g/l

5.43

444

2220

(3039000) Anion gap in Blood

298

1217

2.52

46.46

7.6

6.8

11.13

11.40

mmol/l

0.78

275

1098

(3018572) Chloride [Moles/volume] in Blood

298

1217

2.52

46.46

7.6

6.8

106.01

104.68

mmol/l

4.90

275

1098

(3012544) pH of Venous blood

908

5591

1.72

45.77

3.4

3.6

7.40

7.37

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

882

5408

1.73

45.10

3.4

3.5

5.60

5.85

kpa

11.81

856

5232

(3021589) Normoblasts [#/volume] in Blood

2665

21043

1.45

43.95

14.8

8.8

0.00

e9/l

0.61

2120

17132

(3002032) Base excess in Venous blood by calculation

872

5399

1.71

42.89

3.4

3.5

1.67

1.96

mmol/l

1.26

694

4566

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

569

3113

1.91

42.30

2.6

2.5

—

(3019060) Gas panel - Arterial blood

673

3930

1.79

40.55

5.9

4.6

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

8.31

39.77

2.0

2.3

—

(3036489) Thrombin time

338

1566

2.22

39.51

1.9

1.8

21.36

21.33

0.03

319

1375

(3047181) Lactate [Moles/volume] in Blood

365

1749

2.15

39.22

6.9

6.0

1.45

1.33

mmol/l

1.21

333

1562

(3008152) Bicarbonate [Moles/volume] in Arterial blood

639

3735

1.79

38.28

8.2

6.8

24.18

24.57

mmol/l

1.94

612

3574

(3019225) pH of Specimen

850

5415

1.65

37.17

4.9

3.7

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

252

1099

2.34

33.99

1.4

1.6

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

576

3380

1.77

33.91

1.7

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

174

644

2.75

33.10

5.8

6.1

11.76

12.27

mg/l

0.83

156

575

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

459

2545

1.86

32.53

3.1

3.8

23.70

24.19

mmol/l

2.13

447

2469

(3017181) Myelocytes/100 leukocytes in Blood

620

3759

1.72

32.47

3.1

3.6

1.03

0.81

1.38

275

1020

(3004809) Band form neutrophils/100 leukocytes in Blood

166

608

2.77

32.22

2.4

2.8

2.23

1.31

1.99

151

512

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

290

1378

2.16

31.80

1.7

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

5662

52663

1.54

31.20

33.5

17.7

139.26

139.75

mmol/l

39.18

5577

51119

(3033799) Differential panel - Peritoneal fluid

104

5.62

30.90

1.4

2.1

—

(3025941) Bacteria identified in Stool by Culture

441

2455

1.85

30.83

1.2

1.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

9.52

30.58

6.1

1.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

545

3247

1.74

30.33

1.6

1.5

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

5666

52781

1.53

30.21

33.6

17.8

3.97

4.00

mmol/l

13.06

5572

51153

(3021440) Promyelocytes/100 leukocytes in Blood

592

3620

1.70

29.96

3.1

3.6

0.14

0.08

1.06

248

884

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

242

3.80

29.90

1.3

—

(3024354) Oxygen [Partial pressure] in Venous blood

701

4529

1.61

28.55

3.0

4.58

4.43

kpa

0.95

677

4363

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

5084

46538

1.41

28.24

28.7

13.4

75.55

73.78

ml/min/173m2

7.68

4502

37491

(3021960) Folate [Moles/volume] in Serum or Plasma

1780

13884

1.39

28.17

1.6

20.60

20.39

nmol/l

0.19

1552

11662

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

920

6350

1.52

27.99

1.8

1.7

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

404

2255

1.84

27.98

1.9

1.8

—

(3013512) EKG study

2050

16416

1.36

27.37

4.6

4.3

—

(3002179) Metamyelocytes/100 leukocytes in Blood

557

3434

1.68

27.26

2.9

3.5

0.91

0.59

1.85

234

895

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

658

4247

1.61

26.84

4.5

3.1

1.22

1.23

mmol/l

1.01

605

3548

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

786

5296

1.55

26.63

4.7

3.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2868

24229

1.33

26.42

2.2

2.1

89.96

93.69

pmol/l

3.91

1675

12342

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

159

631

2.56

26.39

1.4

1.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

371

2075

1.83

25.51

1.8

1.7

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

154

613

2.55

25.41

1.4

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

152

602

2.56

25.35

1.4

1.3

—

(40761511) CBC panel - Blood by Automated count

5467

50958

1.43

25.15

27.8

14.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

152

605

2.55

25.09

1.4

1.3

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1604

12498

1.37

25.01

1.7

1.8

1195.54

1155.16

nmol/l

0.81

1222

9326

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

+∞

25.01

1.1

0.0

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

151

601

2.55

24.93

1.4

1.3

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

140

542

2.62

24.47

1.1

1.60

1.55

g/l

0.81

134

479

(3024522) Salmonella sp identified in Specimen by Organism specific culture

152

615

2.51

24.26

1.4

1.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

900

6360

1.48

24.17

1.8

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5608

52694

1.44

23.04

18.7

9.4

25.26

24.98

u/l

0.51

5492

50095

(3007853) Bacteria identified in Skin by Aerobe culture

833

5858

1.48

22.84

1.7

1.8

—

(3025159) Blasts/100 leukocytes in Blood

539

3444

1.62

22.81

3.0

3.7

0.02

0.09

2.14

192

736

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

219

1071

2.08

22.33

1.4

1.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

564

3693

1.58

21.50

1.4

1.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

532

3443

1.59

21.32

1.4

1.5

—

(3049717) Cytology report of Urine Cyto stain

314

1792

1.79

20.20

2.9

1.8

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1436

11315

1.34

20.15

3.8

4.2

418.71

488.30

ng/l

0.15

1224

9622

(3052851) Hemolysis interference index of Serum or Plasma

279

1540

1.85

20.03

4.4

3.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2595

22219

1.28

19.52

4.1

42.44

90.05

ng/l

2.41

2093

16632

(3044889) 12 lead EKG panel

4012

36276

1.27

18.95

4.5

4.2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1360

10730

1.34

18.73

1.7

1.83

1.29

mg/l

5.70

1114

8282

(3023487) Leukocytes [#/volume] in Peritoneal fluid

126

4.07

18.67

1.4

2.5

11453.56

567.54

e6/l

0.51

(3002385) Erythrocyte distribution width [Ratio]

4523

41628

1.28

17.82

35.7

16.6

15.93

15.34

10.08

4482

40687

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

137

3.82

17.45

3.0

2.6

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

539

3656

1.52

17.44

3.1

3.2

119.51

129.62

g/l

17.67

526

3562

(3030981) Hyaline casts [#/volume] in Urine by Automated count

434

2809

1.58

17.34

3.0

2.6

0.30

0.31

e6/l

0.04

429

2743

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

109

4.15

16.94

1.4

2.2

14706.58

32874.88

e6/l

0.40

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

+∞

16.67

1.1

0.0

—

(3000012) Reticulocyte production index

157

759

2.09

16.60

1.9

1.8

—

(3023183) Ammonium ion [Moles/volume] in Plasma

191

997

1.94

16.32

2.1

2.4

30.51

33.69

umol/l

1.20

176

875

(3009261) Glucose [Presence] in Urine by Test strip

2867

25188

1.24

16.27

4.2

4.0

0.00

estimate

0.15

614

4094

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2189

18673

1.26

16.08

3.0

3.2

1703.92

1728.84

ng/l

0.08

1897

16135

(3018405) Lactate [Moles/volume] in Arterial blood

339

2112

1.64

15.86

4.7

3.9

1.35

1.43

mmol/l

0.57

334

2069

(3009542) Hematocrit [Volume Fraction] of Blood

5707

54443

1.37

15.73

43.6

21.2

37.82

39.98

56.11

5323

49797

(3007461) Platelets [#/volume] in Blood

5708

54477

1.36

15.49

43.3

21.1

253.00

241.71

e9/l

24.52

5588

52615

(3024731) MCV [Entitic volume]

5709

54491

1.36

15.46

43.1

21.0

90.90

91.60

20.37

5645

53332

(3026361) Erythrocytes [#/volume] in Blood

5709

54497

1.36

15.39

43.3

21.1

4.26

4.46

e12/l

144.27

5566

52396

(3035941) MCH [Entitic mass]

5708

54492

1.36

15.33

43.1

21.0

29.91

30.46

71.65

5643

53333

(3000963) Hemoglobin [Mass/volume] in Blood

5709

54504

1.36

15.32

43.6

21.2

125.90

135.10

g/l

321.93

5645

53355

(3021601) Nitrite [Presence] in Urine by Test strip

2823

24872

1.24

15.26

5.8

5.2

0.00

estimate

0.72

616

4216

(3010813) Leukocytes [#/volume] in Blood

5708

54501

1.36

15.24

43.3

21.1

7.05

6.81

e9/l

10.16

5577

52391

(3013727) Leukocytes other/100 leukocytes in Blood

105

4.02

15.19

2.3

3.0

54.14

58.75

0.67

(3013707) Erythrocyte sedimentation rate by Westergren method

4104

37696

1.24

14.68

3.9

4.2

18.27

13.15

mm/h

51.74

3707

34438

(3041096) Erythrocytes [Presence] in Urine by Automated

1519

12517

1.28

14.64

4.4

3.6

—

(40761536) Microorganisms panel - Urine sediment

554

3923

1.45

14.41

4.3

4.2

—

(3044007) Cell count panel - Peritoneal fluid

3.97

13.57

1.7

2.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

347

2.47

13.50

1.4

1.3

—

(3003434) Protein [Mass/volume] in Pleural fluid

129

632

2.06

13.25

1.4

1.5

30.99

28.41

g/l

1.45

116

540

(3035350) Ketones [Presence] in Urine by Test strip

2811

25016

1.22

13.04

4.2

3.9

0.00

estimate

2.14

661

4638

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

128

630

2.05

13.00

4.2

4.8

367.87

819.83

iu/ml

0.69

(3012441) Differential panel - Pleural fluid

105

482

2.20

12.77

1.4

1.5

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

251

2.69

12.69

2.5

1.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

186

1049

1.80

12.57

1.3

1.4

—

(3012501) Base excess in Blood by calculation

206

1202

1.74

12.39

4.3

4.2

2.70

2.65

mmol/l

0.08

147

799

(3013290) Carbon dioxide [Partial pressure] in Blood

206

1204

1.73

12.32

4.3

4.2

4.98

5.02

kpa

0.36

200

1169

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

554

4041

1.40

12.20

3.7

2.5

62.84

60.90

ml/min/173m2

0.63

268

1601

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

340

2.40

12.15

1.4

1.3

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

434

3033

1.46

12.09

3.6

3.2

24.56

25.21

mmol/l

3.17

424

2932

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

150

801

1.89

12.08

3.3

3.4

58.39

58.94

0.20

150

801

(3027315) Oxygen [Partial pressure] in Blood

206

1211

1.72

12.07

4.3

4.2

8.94

8.38

kpa

2.49

200

1175

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

236

2.69

11.96

1.3

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

236

2.69

11.96

1.3

1.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

178

1008

1.79

11.89

1.3

1.4

—

(40768806) Pleura Pathology biopsy report

438

2.21

11.88

1.4

1.5

—

(3043410) Blood group antigens tested for on Red Blood Cells

125

3.37

11.88

2.3

1.5

—

(1616796) Gas panel - Central venous blood

202

1187

1.72

11.86

3.5

3.7

—

(3007566) Smooth muscle Ab [Titer] in Serum

195

1139

1.73

11.71

1.2

60.00

186.63

titre

1.39

(3051651) Icteric interference index of Serum or Plasma

253

2.58

11.46

6.4

4.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

116

579

2.02

11.39

1.5

1152.68

3107.64

e6/l

2.02

419

(3020891) Body temperature

349

2374

1.50

11.15

5.6

4.7

—

(3010421) pH of Blood

227

1402

1.64

11.08

4.2

4.1

7.42

0.37

208

1256

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

5.73

10.99

1.2

2.5

61.62

68.67

0.32

(3035637) Corticotropin [Mass/volume] in Plasma

388

2.23

10.97

1.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

137

3.15

10.93

1.5

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

137

3.15

10.93

1.5

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

229

1423

1.63

10.91

1.4

239.71

287.54

ug/g

2.71

148

847

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

308

2052

1.53

10.87

1.9

2.2

361.95

687.97

ug/l

1.94

299

1933

(3021879) Hepatitis B virus core Ab [Presence] in Serum

309

2061

1.52

10.85

1.2

1.3

—

(3045142) Bone marrow Pathology biopsy report

333

2.33

10.85

1.3

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

103

3.51

10.83

1.1

1.3

1150.27

4.36

ug/l

0.85

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

186

2.81

10.81

1.5

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

186

2.81

10.81

1.5

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

138

3.13

10.80

1.5

1.2

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

404

2.19

10.77

1.4

1.3

317.83

297.69

u/l

0.16

372

(3017354) Segmented neutrophils/100 leukocytes in Blood

418

2.17

10.70

2.5

2.6

59.91

60.65

0.12

336

(3008757) Leukocyte morphology finding [Identifier] in Blood

435

2.13

10.47

2.4

3.0

—

(3036782) Glucose [Moles/volume] in Pleural fluid

410

2.16

10.39

1.4

6.47

6.78

mmol/l

0.39

368

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

137

3.08

10.29

5.5

1.1

41.68

95.74

u/ml

0.73

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

258

1675

1.56

10.25

2.4

2.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

125

666

1.89

10.21

1.3

1.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

125

666

1.89

10.21

1.3

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

222

1396

1.61

10.11

1.1

1.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

104

523

2.00

10.05

1.5

175016.62

68124.36

e6/l

0.72

303

(3000494) Fungus identified in Specimen by Culture

712

5561

1.31

10.05

1.4

—

(40767503) Oxygen content in Capillary blood by calculation

186

1120

1.68

10.05

2.3

2.5

15.34

16.27

2.03

589

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

630

8087

0.76

9.92

1.3

41.79

37.76

iu/ml

0.30

209

2505

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

219

1381

1.61

9.87

1.2

—

(3028626) Oxygen [Partial pressure] in Capillary blood

198

1219

1.64

9.83

3.7

2.8

8.02

7.84

kpa

0.44

190

1188

(3009343) pH of Capillary blood

472

3484

1.38

9.69

4.0

3.6

7.42

0.08

419

(42529406) Shigella sp [Presence] in Stool by Culture

221

1403

1.59

9.69

1.1

1.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

135

751

1.81

9.64

1.4

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

477

3533

1.38

9.59

4.1

3.6

5.02

5.17

kpa

3.35

450

3316

(1761482) Bacteria [#/volume] in Urine by Culture

249

1631

1.55

9.54

5.1

4.4

—

(3051611) Lipemic interference index of Serum or Plasma

102

520

1.98

9.51

4.9

3.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

456

3372

1.38

9.27

4.0

3.5

1.75

1.96

mmol/l

0.48

321

2451

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

599

7653

0.76

9.07

1.2

21.15

14.58

u/ml

0.78

218

2735

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

193

1217

1.60

8.74

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

193

1217

1.60

8.74

1.3

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

162

2.73

8.73

1.3

1.4

57.94

64.13

0.50

132

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

3.66

8.70

2.1

2.3

—

(3020876) Protein [Mass/time] in 24 hour Urine

108

580

1.88

8.67

2.6

2.1

1.17

1.38

g/24h

0.34

267

(3045788) Cell count panel - Pleural fluid

441

2.01

8.65

1.5

—

(3024928) Oxygen saturation in Venous blood

188

1183

1.61

8.60

1.9

2.9

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1162

13667

0.82

8.58

1.6

1.41

1.33

mmol/l

2.26

976

11283

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

154

922

1.69

8.56

1.4

1.5

—

(3021901) Oxygen saturation in Capillary blood

169

1039

1.64

8.49

2.6

2.7

—

(21494814) CD8 cells/100 lymphocytes in Specimen

3.38

8.33

2.0

2.2

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

303

2.19

8.18

1.3

13.73

11.63

u/l

0.28

269

(3001893) Eosinophils/100 leukocytes in Pleural fluid

136

2.80

7.98

1.4

3.85

2.62

0.23

115

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

476

1.92

7.95

3.0

2.9

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

135

812

1.68

7.43

2.6

2.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

397

1.98

7.40

1.4

—

(3023383) Lactate [Moles/volume] in Pleural fluid

132

2.74

7.26

1.3

3.67

3.01

mmol/l

0.41

117

(3007164) IgA [Mass/volume] in Serum or Plasma

945

7928

1.22

7.25

1.5

1.3

2.62

2.65

g/l

0.13

533

4366

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

430

1.92

7.15

1.4

1.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1462

12797

1.18

7.09

1.7

14701423.83

26220057.00

pmol/l

0.48

1204

10290

(3042111) Morphology [Interpretation] in Bone marrow Narrative

111

642

1.74

7.07

1.5

1.2

—

(21494815) CD4 cells/100 lymphocytes in Specimen

194

2.38

7.00

1.8

2.0

33.92

42.58

2.51

185

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

182

2.43

6.98

2.7

2.6

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2313

21018

1.15

6.91

2.2

76.29

79.02

nmol/l

4.62

2075

18208

(3000330) Specific gravity of Urine by Test strip

397

3012

1.34

6.89

5.1

3.7

—

(3035880) pH of Pleural fluid

259

2.17

6.88

1.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

466

1.83

6.51

1.2

1.1

—

(3020630) Protein [Mass/volume] in Serum or Plasma

568

4558

1.27

6.49

2.5

1.6

65.18

66.54

g/l

3.53

509

3998

(3015736) pH of Urine

2216

20147

1.15

6.46

3.9

3.7

5.78

5.84

0.29

844

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

363

1.94

6.36

1.4

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

363

1.94

6.36

1.4

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

363

1.94

6.36

1.4

1.2

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

203

2.27

6.35

1.3

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

203

2.27

6.35

1.3

1.4

—

(3017732) Neutrophils [#/volume] in Blood

415

3214

1.31

6.26

3.8

3.1

4.89

5.51

e9/l

0.45

312

2381

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1106

9558

1.19

6.14

1.2

2.28

1.87

u/ml

0.35

281

2449

(3015235) Bicarbonate [Moles/volume] in Capillary blood

206

1440

1.44

5.89

2.7

3.0

24.21

24.92

mmol/l

1.54

201

1409

(3020393) Adenovirus Ag [Presence] in Stool

3.78

5.80

1.1

1.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

256

1867

1.39

5.77

1.2

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

185

1275

1.46

5.71

2.0

2.2

120.28

129.85

g/l

5.14

140

946

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

157

2.36

5.62

2.0

—

(3019977) pH of Arterial blood

331

1.91

5.56

3.4

2.3

7.41

7.42

0.32

124

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

687

5733

1.22

5.53

3.2

222.07

238.98

ng/l

0.52

629

5259

(4034850) Laboratory test

123

1878

0.65

5.39

14.7

11.0

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

118

750

1.58

5.34

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

497

1.72

5.32

1.3

1.5

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

490

1.72

5.30

1.1

79.84

56.80

u/l

1.17

429

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4713

48820

0.88

5.28

4.3

4.8

1.42

1.45

mmol/l

3.07

4195

44263

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

131

2.45

5.27

2.4

1.3

27.53

29.50

umol/l

0.53

121

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

162

2.29

5.26

1.9

2.0

16.84

17.51

0.13

156

(46235355) HIV 1 and 2 tests - Meaningful Use set

537

4392

1.24

5.24

1.5

1.6

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4761

49270

0.88

5.19

4.3

4.8

4.44

4.49

mmol/l

2.60

4283

45012

(3022313) Gas panel - Capillary blood

326

2521

1.31

5.03

4.5

3.7

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

468

1.72

5.02

1.8

2.4

3.10

2.01

u/field

0.66

163

(3036481) Cortisol [Moles/volume] in Serum or Plasma

481

3914

1.25

4.92

2.6

1.8

407.32

370.91

nmol/l

2.73

449

3486

(40761539) Cells [Type] in Urine sediment by Light microscopy

106

2.55

4.86

1.1

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

4.55

4.85

1.2

2.2

22.86

9.67

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2627

24476

1.12

4.83

2.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

298

1.89

4.81

2.0

1.7

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2087

19194

1.13

4.77

4.7

4.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

343

1.81

4.72

1.5

1.8

269.96

1931.84

u/l

1.26

133

(3048689) Calprotectin [Mass/mass] in Stool

601

5034

1.21

4.68

1.9

2.1

271.19

155.74

ug/g

6.33

471

3914

(3003181) Sodium [Moles/volume] in Urine

149

1028

1.46

4.65

1.4

1.3

51.29

62.31

mmol/l

3.49

101

820

(3045424) Erythrocytes [Presence] in Urine

124

826

1.51

4.61

1.7

1.5

—

(40758292) HTLV I+II Ab panel - Serum

6.12

4.59

1.6

1.2

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

10.01

4.51

2.0

1.5

204.63

207.63

ng/l

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

10.01

4.51

1.6

1.8

73.38

169.00

umol/l

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

146

1013

1.45

4.44

1.5

1.6

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

197

2.04

4.31

1.5

1.6

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

453

0.37

4.31

1.0

42.22

46.21

ng/l

—

286

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

107

2.44

4.29

1.3

1.4

26.24

29.29

0.19

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

451

0.38

4.27

1.0

659.20

706.77

ng/l

—

282

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2218

20583

1.12

4.23

5.0

4.0

3.47

2.12

ug/l

2.56

1938

18318

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

448

0.38

4.22

1.0

251.00

336.31

ng/l

—

290

(3011648) Oxygen content in Venous blood

410

1.69

4.16

1.5

2.0

11.10

10.94

0.11

410

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

628

1.55

4.14

1.3

1.4

—

(3029937) Albumin [Presence] in Urine by Test strip

1522

13841

1.13

4.09

4.5

4.3

0.00

estimate

0.21

564

4091

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

277

2167

1.29

3.99

4.9

3.9

24.64

24.92

mmol/l

0.65

248

1961

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

2.82

3.95

1.3

1.4

7.11

6.00

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

299

1.78

3.85

1.5

3.76

8.10

u/l

2.43

242

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

139

2.16

3.81

2.0

2.3

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

6.01

3.81

1.3

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

156

1130

1.39

3.80

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.94

3.56

1.2

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

120

1687

0.71

3.55

1.4

1.5

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

128

1776

0.72

3.51

1.1

1.2

0.22

0.88

u/ml

—

178

(3002331) Protein [Mass/volume] in Peritoneal fluid

2.42

3.46

1.2

1.5

30.57

90.29

g/l

0.44

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1218

0.66

3.44

1.6

1.7

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

223

1.84

3.39

1.7

4.8

63.31

70.90

mg/l

0.29

146

(3045414) Leukocytes [Presence] in Urine

284

2278

1.26

3.39

2.1

1.9

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

404

4807

0.83

3.28

1.5

—

(3022475) Manganese [Moles/volume] in Blood

5.34

3.19

1.6

1.0

—

(40765096) Chromosome analysis panel by Banding

2.73

3.15

1.0

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

296

1.69

3.14

1.2

1.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

113

804

1.41

3.12

1.2

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

182

1396

1.31

3.12

2.9

2.6

—

(3042631) Mycobacterium sp identified in Specimen

665

1.45

3.07

2.3

3.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

391

1.59

3.06

1.3

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

625

1.46

3.04

1.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4664

47881

0.91

3.00

6.5

41.27

40.96

mmol/mol

1.38

4192

43682

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

4.29

2.99

1.2

1.0

—

(3017569) Oxygen content in Arterial blood

302

1.66

2.94

2.3

1.9

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

483

1.52

2.94

1.2

1.4

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

483

1.52

2.94

1.2

1.4

—

(3037756) Immunofixation for Serum or Plasma

146

1098

1.34

2.89

1.7

1.2

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

273

1.69

2.89

1.1

1.2

226.85

80.63

u/l

0.88

230

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

266

1.70

2.87

1.1

1.2

49.66

19.21

u/l

1.17

220

(3005719) IgG [Mass/volume] in Serum or Plasma

357

2991

1.20

2.87

2.5

2.2

10.58

10.78

g/l

0.28

321

2714

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

2.59

2.87

1.7

1.2

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

5.39

2.86

2.0

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

650

1.44

2.86

1.3

1.4

—

(3048879) Bone marrow aspiration report

122

2.05

2.86

1.5

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

100

710

1.41

2.83

1.3

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.34

2.81

2.1

1.5

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.77

2.81

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4945

50577

0.91

2.80

4.8

5.5

2.55

2.61

mmol/l

3.83

4416

46037

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

330

1.61

2.79

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

187

1.82

2.77

1.0

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

214

1709

1.26

2.72

1.6

—

(3004588) Protein electrophoresis panel - Serum or Plasma

460

3963

1.17

2.71

2.3

1.5

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4605

47217

0.92

2.66

3.9

4.3

1.33

1.28

mmol/l

5.27

4065

42381

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

272

2238

1.22

2.65

2.4

1.4

7.61

7.55

g/l

0.26

241

1947

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

271

2230

1.22

2.64

2.4

1.4

3.68

3.75

g/l

0.50

241

1941

(3037522) Nuclear Ab [Titer] in Serum

543

6184

0.87

2.62

1.3

519.02

537.39

titre

0.08

122

1385

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.66

2.62

1.0

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

211

2613

0.80

2.60

1.8

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

271

2235

1.22

2.59

2.4

1.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

287

2383

1.21

2.57

2.0

1.4

1.72

1.18

g/l

1.09

258

2135

(3012565) Volume of 24 hour Urine

223

1.71

2.53

2.1

1647.37

1858.07

0.74

188

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

118

881

1.35

2.50

3.1

3.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

867

0.67

2.49

1.1

1.2

61.20

46.23

u/ml

—

105

(3006270) Folate [Moles/volume] in Blood

552

1.44

2.48

1.3

1.2

315.22

336.44

nmol/l

0.36

425

(3035320) C reactive protein [Mass/volume] in Body fluid

333

1.57

2.47

2.5

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

224

2732

0.81

2.42

1.3

57.57

56.20

au/ml

0.04

148

(3027456) Digoxin [Moles/volume] in Serum or Plasma

192

1539

1.25

2.41

3.2

0.86

0.83

nmol/l

0.19

150

1210

(3017446) Testosterone [Moles/volume] in Serum or Plasma

319

2696

1.19

2.39

2.0

2.2

10.46

14.47

nmol/l

13.02

275

2343

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

192

0.36

2.39

1.0

1.7

31.83

201.67

ug/l

—

177

(3003327) Ova and parasites identified in Stool by Light microscopy

168

1328

1.27

2.37

1.6

1.7

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

144

1116

1.30

2.37

3.2

2.6

1.91

1.78

mg/l

0.74

127

972

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

251

1.64

2.35

1.4

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

627

1.39

2.32

1.3

1.4

—

14.53

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1282

0.74

2.31

1.4

1.6

4.17

3.95

mg/l

0.09

945

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

277

1.59

2.27

1.7

2.1

2.26

2.24

u/field

0.01

181

(3036603) Volume of Urine

301

1.57

2.26

1.5

1.4

1735.91

1837.52

0.31

282

(3048929) Epstein Barr virus Ab [Presence] in Serum

107

802

1.34

2.25

1.2

—

(1761868) Lipid panel - Serum or Plasma

1372

14692

0.92

2.22

3.0

3.3

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

497

4379

1.15

2.21

1.4

1.7

1.53

1.55

0.29

426

3706

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1228

11390

1.10

2.20

3.1

2.8

0.86

0.73

ug/l

2.48

865

7954

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.86

2.20

1.1

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

304

1.55

2.18

1.4

1.5

14.48

13.92

umol/l

0.12

282

(3009466) Valproate [Moles/volume] in Serum or Plasma

710

0.66

2.17

3.9

4.3

347.15

350.20

umol/l

0.05

587

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

480

4227

1.15

2.16

3.7

103.79

97.06

ng/l

0.77

425

3534

(21494755) Public health laboratory ask at order entry panel

178

2194

0.81

2.16

1.3

1.4

—

(4200892) Spirometry reversibility

336

3902

0.85

2.15

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

251

1.60

2.11

1.4

—

(3014271) Vancomycin [Susceptibility]

396

1.47

2.10

2.9

3.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

3.20

2.09

3.1

1.8

—

(21494434) Karyotype in Bone marrow

372

1.48

2.09

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

300

1.54

2.07

1.4

1.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

249

2089

1.20

2.06

2.4

1.4

3.09

2.95

g/l

1.21

218

1798

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

256

3028

0.84

2.05

2.4

23.41

23.62

au/ml

0.01

155

(4094501) Cardiovascular stress test using bicycle ergometer

113

1453

0.77

1.99

1.1

—

(3004451) EKG impression Narrative

296

1.52

1.96

1.2

1.3

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.96

1.93

7.6

1.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

3.75

1.93

3.8

3.4

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

3.75

1.93

7.7

6.7

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

248

2095

1.19

1.93

2.5

1.4

10.14

10.24

g/l

0.11

216

1792

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

2.05

1.90

1.8

1.1

3.37

2.85

ug/l

0.11

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1000

0.74

1.88

1.3

23.90

26.73

e6/l

0.06

788

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.00

1.88

0.0

1.8

—

18.07

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

593

1.35

1.86

1.1

1.0

—

(3006462) Nitrate [Presence] in Urine

252

1.55

1.86

4.1

3.3

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

2.09

1.86

1.3

1.2

41.63

129.39

ug/l

—

(3032057) Clostridioides difficile [Presence] in Stool

129

1.79

1.85

1.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

125

988

1.27

1.84

1.2

1.3

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

315

0.54

1.82

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

451

1.40

1.82

1.0

1.1

6.51

2.67

u/ml

0.39

154

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

183

1.64

1.81

4.0

2.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

183

1.64

1.81

4.0

2.3

—

(3052592) Norovirus Ag [Presence] in Stool

130

1.77

1.81

1.3

1.4

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

314

0.54

1.80

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

314

0.54

1.80

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1002

0.75

1.78

1.4

193.54

1286.01

e6/l

2.60

832

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

642

1.33

1.77

1.2

1.3

—

(3019150) Specific gravity of Urine by Refractometry

1094

11714

0.92

1.76

4.4

1.02

kg/l

0.27

191

1779

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

311

0.55

1.75

1.2

1.7

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

311

0.55

1.75

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

311

0.55

1.75

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

3.33

1.74

1.0

1.1

190.00

257.06

nmol/l

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

310

0.55

1.74

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

225

1.56

1.72

1.1

1.3

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

3.85

1.71

1.2

1.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.29

1.70

1.2

1.9

—

(40760888) Immunoglobulin light chains.free panel - Serum

162

1333

1.22

1.70

2.4

1.5

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

526

1.35

1.69

4.3

3.8

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

137

1109

1.24

1.68

1.1

7.74

9.73

u/ml

0.16

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

658

1.31

1.65

1.3

0.60

3.98

nmol/l

0.82

631

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.10

1.65

2.0

1.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

309

1.46

1.65

1.1

1.2

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

220

1.55

1.64

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

220

1.55

1.64

1.1

1.0

—

(40768443) Skin Pathology biopsy report

239

2047

1.17

1.63

1.3

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

547

1.34

1.63

1.3

1.4

119.25

122.70

u/ml

0.09

107

(3041918) Cholesterol [Moles/volume] in Pleural fluid

1.87

1.60

1.6

1.2

1.18

1.31

mmol/l

—

(3005322) IgE [Units/volume] in Serum or Plasma

218

2548

0.85

1.58

1.2

1.3

207.68

235.25

u/ml

0.25

198

2348

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.00

1.58

1.0

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

603

1.31

1.56

1.3

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

577

1.32

1.56

1.3

—

nmol/l

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

785

0.74

1.54

1.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

232

1.51

1.53

1.1

—

(3022621) pH of Urine by Test strip

403

3604

1.13

1.51

3.1

3.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

182

0.49

1.50

1.6

1.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

669

1.29

1.49

1.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

669

1.29

1.49

1.1

—

(3008898) HLA-B27 [Presence]

1085

0.78

1.49

1.0

1.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

208

1778

1.18

1.48

2.7

1.5

1.41

2.21

ratio

1.00

145

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

121

1479

0.81

1.46

1.6

1.7

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

213

1828

1.17

1.45

2.7

1.5

40.68

33.85

mg/l

1.11

182

1461

(3011397) Hemoglobin [Presence] in Urine by Test strip

1318

12472

1.07

1.44

3.6

3.9

—

(3004775) Volume in Urine collected for unspecified duration

499

1.33

1.42

2.2

2.3

766.69

633.24

0.94

339

(3034860) Kappa light chains.free [Mass/volume] in Serum

213

1832

1.17

1.42

2.7

1.5

87.85

47.14

mg/l

0.81

182

1472

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

329

1.40

1.0

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

225

0.53

1.39

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

590

1.29

1.37

1.3

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

714

1.26

1.37

2.2

2.3

32.32

26.36

mg/l

0.36

171

(3040151) Glucose [Moles/volume] in Capillary blood

652

1.28

1.36

9.1

18.3

7.41

7.44

mmol/l

0.02

530

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

298

0.60

1.35

1.3

1.4

161.59

198.16

pmol/l

0.48

298

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

0.00

1.34

0.0

2.4

—

1.33

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

2.13

1.33

1.1

12.82

8.91

mg/l

—

(44813793) Dust mix specific IgE antibody measurement

272

0.59

1.33

1.1

1.0

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

284

0.60

1.32

1.0

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1729

16550

1.06

1.32

4.4

3.9

22.44

24.55

7.29

915

8208

(3014148) Varicella zoster virus Ab [Titer] in Serum

331

0.63

1.29

1.2

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.08

1.27

1.0

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.05

1.26

1.3

1.1

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1466

13988

1.06

1.24

2.9

2.5

4229.72

6287.99

umol/l

1.18

1281

11874

(3029075) Extractable nuclear Ab panel - Serum

117

0.43

1.24

1.0

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1710

17818

0.95

1.24

2.0

2.2

243.44

237.47

u/l

0.08

1614

16565

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1034

0.80

1.24

1.2

—

16.91

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

564

1.28

1.23

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

100

1.70

1.23

1.3

1.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

218

1906

1.15

1.21

1.7

38.48

38.42

u/l

0.01

193

1591

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

383

0.68

1.19

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.31

1.18

1.8

2.2

—

(36660697) Celiac disease serology panel - Serum

381

3453

1.11

1.18

1.2

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

113

1353

0.83

1.16

1.4

1.5

1.14

1.17

g/l

0.53

107

1271

(21494890) Protein electrophoresis panel - 24 hour Urine

518

1.28

1.14

1.7

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

134

1.57

1.14

1.1

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.85

1.13

1.2

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

492

1.28

1.13

1.1

—

(3003338) MCHC [Mass/volume]

4119

40441

1.05

1.12

39.0

19.1

328.38

331.92

g/l

94.31

4088

40022

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3695

37693

0.95

1.12

3.7

3.8

15.01

15.03

pmol/l

0.10

3260

33571

(3009871) Measles virus Ab [Titer] in Serum

114

0.44

1.12

1.4

1.7

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

780

1.22

1.11

1.1

1.2

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1107

0.82

1.11

1.6

1.8

39.14

43.92

nmol/l

1.41

1057

(3009214) Lutropin [Units/volume] in Serum or Plasma

672

1.24

1.11

1.3

16.75

9.37

u/l

2.49

529

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

127

1.58

1.11

2.1

2.3

37.08

44.45

1.15

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

176

1.48

1.09

1.0

1.1

—

(3036525) Urea [Moles/time] in 24 hour Urine

2.12

1.05

3.0

3.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

228

0.61

1.03

1.2

1.4

1.58

1.55

g/l

0.19

228

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.06

1.02

1.9

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

106

1.60

1.02

1.0

1.3

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

112

1322

0.84

1.01

1.3

1.5

0.23

g/l

0.23

107

1247

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

491

5297

0.92

1.01

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

209

1851

1.13

1.00

2.6

1.5

1.14

0.41

g/l

1.59

175

1544

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

197

1.42

0.99

2.3

2.6

42135.71

40433.59

ug/l

0.21

197

(1002224) Polysomnography panel

118

1382

0.85

0.98

1.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

135

1162

1.16

0.97

1.7

1.8

11.70

11.78

mg/l

0.04

125

1064

(3011288) Drugs identified in Urine by Screen method

331

0.69

0.97

1.3

1.9

—

(3044927) Protein electrophoresis panel - Urine

657

1.22

0.97

1.2

—

(3044941) Cell count panel - Synovial fluid

933

0.82

0.94

1.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.65

0.94

1.1

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

209

0.62

0.93

1.2

1.1

—

(3022689) Creatine [Moles/volume] in Urine

172

0.58

0.93

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

554

1.23

0.90

1.3

1.2

320.56

281.89

u/ml

0.36

346

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

118

1.53

0.90

1.0

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

626

5881

1.07

0.90

2.3

2.5

4.90

7.24

ug/l

3.55

525

5011

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

440

0.75

0.90

1.1

—

1.91

—

(3000475) Leukocytes [#/volume] in Synovial fluid

127

1465

0.86

0.89

1.7

1.5

16676.42

14022.11

e6/l

0.31

1041

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

358

0.73

0.87

1.0

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

109

1267

0.86

1.1

1.2

50.00

44.93

u/ml

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

238

1.35

0.85

1.4

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

856

0.83

0.85

1.7

1.6

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

102

1190

0.85

0.84

1.2

2.95

5.53

u/ml

1.53

199

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

726

6872

1.06

0.84

4.3

4.9

33.27

33.20

0.06

467

4572

(3006653) Thiamine [Moles/volume] in Blood

230

1.35

0.84

1.0

1.2

129.87

137.66

nmol/l

0.27

230

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

248

1.33

0.83

2.8

2.3

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

101

1177

0.86

0.83

1.1

1.2

5.33

7.89

u/ml

0.29

126

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

105

1.52

0.81

1.0

1.1

82.78

86.35

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.82

0.79

1.2

1.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.67

0.78

1.1

1.2

—

(3028300) Cannabinoids [Presence] in Urine

518

0.79

0.77

1.3

1.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

135

1530

0.88

0.77

1.5

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

182

1632

1.12

0.77

2.6

1.5

0.17

0.02

g/l

0.44

164

1462

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

539

0.80

0.76

1.4

1.7

16.71

23.87

u/ml

—

131

(1001926) Buprenorphine [Presence] in Urine by Screen method

393

0.76

0.75

1.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

244

1.31

0.75

1.3

1.5

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.54

0.75

1.6

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

2.08

0.74

1.0

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

459

0.78

0.74

1.2

1.3

76.00

483.60

titre

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

360

1.25

0.74

1.2

1.8

86.64

91.94

umol/l

0.38

360

(3012516) Albumin [Mass/volume] in Urine

1834

17829

1.04

0.73

3.3

3.2

332.53

323.98

mg/l

0.03

1238

11391

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.64

0.73

1.0

1.6

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.64

0.73

2.8

1.4

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

194

1753

1.11

0.73

2.7

1.4

36.84

37.39

g/l

0.58

161

1461

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

108

0.56

0.72

1.2

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

589

1.19

0.72

3.3

3.0

57.69

34.54

mg/l

0.29

439

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

422

0.78

0.70

1.1

—

48.76

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.92

0.70

1.0

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

182

0.66

0.70

1.3

1.4

—

(3016750) Collection duration of Urine

336

1.25

0.70

2.3

2.1

506.24

496.42

min

0.29

255

(4212803) Bone marrow aspirate examination

1.71

0.69

1.1

1.0

—

(3010838) Calcium [Moles/time] in 24 hour Urine

823

1.16

0.69

1.5

1.9

4.68

4.79

mmol/24h

0.09

692

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

641

0.83

0.69

1.1

1.2

132.40

206.41

miu/ml

1.07

249

(44816559) Phosphatidylethanol [Mass/volume] in Blood

717

0.84

0.69

1.2

1.3

—

(3020491) Glucose [Moles/volume] in Blood

387

0.77

0.69

1.6

2.3

8.24

7.07

mmol/l

0.79

260

(3009508) Creatinine [Moles/volume] in Urine

1863

18139

1.04

0.69

3.2

3.1

7.45

7.25

mmol/l

1.14

1544

15087

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

181

0.66

0.69

1.1

—

574.68

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

157

0.64

0.68

1.6

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.64

0.68

1.3

1.0

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

257

1.29

0.68

1.3

32.71

34.85

u/l

0.12

182

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

159

1766

0.90

0.67

1.6

1.7

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.55

0.67

1.2

1.1

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.63

0.66

1.3

1.5

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

420

1.22

0.66

1.1

1.2

98.54

94.23

0.68

392

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

267

1.27

0.66

2.2

1.8

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

706

1.16

0.66

1.4

1.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1937

18890

1.04

0.65

3.9

3.8

10.39

9.17

mg/mmol

0.49

1273

11882

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

164

1480

1.11

0.65

1.4

7.18

20.43

iu/ml

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.59

0.65

1.0

—

(3028717) Thiamine [Mass/volume] in Blood

1.59

0.65

1.0

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.57

0.65

1.0

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

990

0.87

0.65

1.2

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

706

7388

0.95

0.64

11.6

7.6

—

(3044290) Cell count panel - Cerebral spinal fluid

891

0.86

0.63

1.3

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.52

0.62

2.6

2.7

0.92

0.47

u/field

0.57

(3027008) Opiates [Presence] in Urine

512

0.82

0.61

1.3

1.5

—

(3000764) Benzodiazepines [Presence] in Urine

511

0.82

0.61

1.3

1.5

—

(3024869) Neuronal Ab [Presence] in Serum

1.48

0.60

1.0

1.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

0.60

0.0

10.1

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

0.00

0.59

0.0

1.7

—

0.83

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

0.59

0.0

9.2

—

152.71

—

(3028707) Methadone [Presence] in Urine by Screen method

243

0.74

0.59

1.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

174

0.69

0.59

1.9

1.2

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

192

1759

1.09

0.58

1.1

9.44

1.26

u/ml

—

(3002619) Bacteria identified in Specimen by Culture

1.46

0.57

1.5

1.2

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

989

0.88

0.57

1.1

1.2

2.79

8.14

u/ml

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.48

0.57

1.1

1.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

310

1.23

0.56

2.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

708

1.15

0.56

1.2

1.3

39.65

32.93

iu/l

0.74

609

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

218

0.73

0.56

1.2

1.1

1.10

1.08

ratio

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.56

0.55

2.6

1.8

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

393

1.20

0.55

2.2

2.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

476

1.18

0.55

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

240

0.75

0.55

1.2

1.4

—

(40757494) Bilirubin.total [Moles/volume] in Blood

302

1.23

0.55

2.4

1.8

21.22

15.96

umol/l

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

143

1574

0.91

0.55

1.6

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

182

0.71

0.54

1.1

3.10

1.06

u/l

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

108

1.39

0.53

1.1

79.75

84.80

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

166

1522

1.09

0.52

2.8

1.5

0.01

0.00

g/l

0.69

148

1357

(3043238) Trisomy 21 risk [Likelihood] in Fetus

132

0.68

0.51

1.7

1.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

112

1007

1.11

0.51

1.4

1.5

0.82

0.80

nmol/l

0.12

834

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

168

0.71

0.50

1.7

1.5

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

118

1.36

0.50

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

575

1.15

0.50

1.2

2.90

4.83

u/ml

1.15

252

(3051387) C reactive protein [Mass/volume] in Capillary blood

136

1239

1.10

0.49

3.7

33.22

27.39

mg/l

0.88

818

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

229

2454

0.93

0.49

1.1

1.2

109.11

126.06

iu/ml

0.31

897

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

127

1.34

0.49

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

267

2503

1.07

0.49

2.9

4.23

4.38

pmol/l

1.99

229

2143

(3026389) Candida sp identified in Specimen by Organism specific culture

661

1.14

0.48

1.1

1.4

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

539

1.15

0.48

1.1

1.2

113.65

116.47

0.32

477

(3014891) Appearance of Pleural fluid

1.40

0.48

1.6

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

587

1.14

0.47

1.2

4.29

3.71

u/ml

0.10

180

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

272

1.21

0.47

4.1

4.4

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.47

0.47

1.0

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.47

0.47

1.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

1.46

0.46

6.6

5.3

45.71

43.88

ug/min

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4921

49549

0.97

0.46

4.9

5.1

6.16

6.08

mmol/l

3.65

4408

44418

(3006576) Bicarbonate [Moles/volume] in Blood

218

1.24

0.46

4.7

6.5

24.82

24.79

mmol/l

0.01

197

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

200

1.25

0.46

1.3

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.40

0.45

1.0

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

732

1.12

0.45

1.7

1.5

63.23

61.45

0.15

460

(3027944) Amphetamines [Presence] in Urine

502

0.86

0.44

1.3

1.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

274

0.80

0.43

1.6

1.5

—

(3005033) Fetal Nuchal fold Thickness US

127

0.71

0.43

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

128

0.70

0.43

1.6

1.4

—

(3023419) Bacteria identified in Sputum by Culture

877

1.11

0.43

2.9

2.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

200

2139

0.93

0.43

1.2

1.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.61

0.43

1.0

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.66

0.42

1.5

1.4

—

(3008295) Osmolality of Serum or Plasma

490

1.14

0.42

1.1

1.4

274.27

276.25

mosm/kgh2o

0.22

361

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.64

0.42

1.3

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.63

0.42

1.0

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.41

0.0

1.0

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

0.07

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.41

0.0

1.0

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

240

1.21

0.41

1.1

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

161

0.74

0.41

6.7

12.3

0.77

0.67

mmol/l

0.44

148

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

37.24

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

16.60

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.40

0.0

1.1

—

8.19

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

160

0.75

0.39

1.1

—

(3016879) Cocaine [Presence] in Urine

475

0.86

0.39

1.3

1.6

—

(3044009) aPTT.lupus sensitive (LA screen)

1.43

0.39

1.0

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

485

0.86

0.39

1.1

0.53

1.46

u/ml

1.67

253

(40761535) Cells panel - Urine sediment

468

4867

0.96

0.39

3.7

3.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

344

3282

1.05

0.38

1.2

—

(3028433) Virus identified in Specimen by Culture

142

1.27

0.38

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.36

0.38

1.8

2.2

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

269

0.82

0.38

2.0

1.4

4.90

6.28

u/l

1.76

221

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

611

0.88

0.38

1.1

1.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.34

0.38

1.8

2.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.34

0.38

2.1

1.7

44.11

44.25

umol/l

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

312

0.83

0.37

1.3

1.2

0.18

1.11

u/ml

2.04

186

(4146454) Self-monitoring of blood glucose

695

1.11

0.37

2.4

2.7

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

987

0.91

0.37

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

115

0.70

0.37

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.36

0.36

1.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

235

1.19

0.36

1.0

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.33

0.35

1.3

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

201

0.80

0.35

3.1

2.2

52.44

55.32

umol/l

0.19

170

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

144

1.25

0.35

4.8

7.9

—

(3051101) Glucose [Moles/volume] in Cord blood

145

0.76

0.34

5.3

6.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

228

1.18

0.33

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.28

0.32

1.7

1.8

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

132

0.76

0.32

1.0

1.2

—

34.79

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

154

0.78

0.32

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

154

0.78

0.32

1.5

1.4

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

128

1.25

0.31

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

164

1544

1.06

0.31

2.2

118.21

106.81

ug/min

0.11

901

(3033923) Metanephrine [Moles/time] in 24 hour Urine

119

1.26

0.31

1.1

0.70

0.65

umol/24h

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

997

0.92

0.31

1.3

—

(3018133) Calcium [Moles/volume] in Urine

1.35

0.31

1.3

1.7

1.47

2.71

mmol/l

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.32

0.30

1.1

1.2

1.61

1.76

umol/24h

—

(3021788) Differential panel - Synovial fluid

1068

0.93

0.30

1.6

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

153

0.78

0.30

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

153

0.78

0.30

1.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

153

0.78

0.30

1.1

1.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

400

0.87

0.30

1.0

1.1

1.72

0.91

u/ml

0.28

163

(3025018) Bordetella pertussis Ab [Titer] in Serum

184

1.20

0.30

1.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

343

1.14

0.30

1.1

1.3

1.12

1.20

promille

0.14

257

(3009445) Proteinase 3 Ab [Units/volume] in Serum

246

2348

1.05

0.30

1.4

1.5

20.89

19.67

u/ml

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

216

2055

1.05

0.30

1.0

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

185

0.81

0.29

1.9

2.1

123.14

139.45

umol/l

—

106

(42529582) MDA5 Ab [Presence] in Serum by Line blot

152

0.79

0.29

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

152

0.79

0.29

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

152

0.79

0.29

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

152

0.79

0.29

1.0

1.1

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

194

1842

1.05

0.29

1.5

1.6

425.71

314.31

titre

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

184

0.81

0.28

1.3

1.2

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

471

0.89

0.28

1.6

1.9

—

2.86

—

(3032773) Endomysium IgG Ab [Titer] in Serum

345

1.13

0.28

1.2

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

574

1.10

0.28

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

158

1495

1.06

0.27

2.8

1.5

0.00

g/l

-0.00

147

1353

(40757373) Influenza virus identified in Isolate

119

0.76

0.27

1.2

1.4

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

120

0.75

0.27

1.7

1.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

290

1.14

0.26

1.1

1.3

1.24

1.20

nmol/l

0.08

221

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

262

1.15

0.26

1.1

1.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

352

0.88

0.26

1.3

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

141

1.21

0.26

1.2

91.35

153.29

nmol/l

1.86

102

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

132

1.21

0.25

1.1

1.5

—

(3034426) Prothrombin time (PT)

132

1.21

0.25

1.1

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

170

0.82

0.25

1.2

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

403

0.89

0.24

1.5

1.7

—

1222.86

—

(3000285) Sodium [Moles/volume] in Blood

1.25

0.24

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

137

0.80

0.24

1.1

0.74

1.73

u/ml

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.28

0.24

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

880

1.07

0.24

1.2

33.75

24.19

u/l

0.91

749

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

129

1361

0.95

0.23

1.5

1.6

4.52

4.64

iu/ml

0.01

320

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

681

0.92

0.23

1.2

1.1

13001.61

621.83

iu/ml

0.45

136

(3019174) dRVVT (LA screen)

1.28

0.23

1.0

1.1

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

1.27

0.22

1.3

1.8

31.40

26.45

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

1.19

0.21

1.6

1.1

37.26

58.01

u/ml

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.3

—

3.60

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.2

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.21

0.0

1.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

884

0.94

0.21

1.3

1.4

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.21

0.0

3.8

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.24

0.20

1.3

1.1

—

(3015183) Erythrocyte sedimentation rate

145

1.17

0.20

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

278

1.12

0.20

1.0

1.1

6.34

2.50

u/ml

—

111

(3002079) Sodium [Moles/time] in 24 hour Urine

208

0.86

0.20

1.1

1.2

139.89

166.48

mmol/24h

0.70

208

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

1.18

0.19

3.8

2.8

—

32.32

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.18

0.19

4.2

4.4

—

(3025577) Chromium [Mass/volume] in Blood

425

0.92

0.18

2.0

1.88

2.15

ug/l

0.36

359

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

216

0.88

0.17

1.2

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

121

1264

0.96

0.17

1.6

1.7

—

(3017704) Immunofixation for Urine

310

1.10

0.17

1.6

1.2

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

0.76

0.17

1.2

1.6

6421.80

479.68

mu/l

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

0.75

0.17

1.2

1.6

74.40

72.55

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

272

1.10

0.17

1.2

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

129

1.16

0.17

2.6

2.4

7.66

7.95

mmol/l

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

0.72

0.16

10.0

12.3

7.98

4.96

mmol/l

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.16

0.16

1.1

1.6

—

(3035933) Granulocytes/100 leukocytes in Blood

1.14

0.16

1.3

1.6

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

162

0.86

0.16

1.2

1.5

4.56

8.30

ug/l

3.15

143

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

525

0.93

0.16

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

273

1.10

0.16

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

411

0.92

0.15

1.0

1.1

6.69

3.64

u/ml

0.28

195

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

119

0.84

0.15

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.15

0.15

2.6

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

296

0.91

0.14

1.2

1.1

3.32

8.35

nmol/l

—

(21491868) Cryoglobulin [Mass/volume] in Serum

160

0.87

0.14

1.4

1.2

—

0.10

g/l

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

501

0.94

0.14

1.3

1.2

—

(3001186) Copper [Moles/volume] in Serum or Plasma

0.82

0.13

1.1

16.92

16.08

umol/l

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

189

1.11

0.13

1.9

61.69

49.25

ug/l

0.89

182

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

149

0.87

0.13

1.1

1.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

315

1.08

0.13

1.1

1.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

461

1.06

0.13

1.2

1.4

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

138

0.87

0.13

1.3

1.5

—

(3042733) HLA Ab [Presence] in Serum

110

0.82

0.13

2.8

5.0

—

(3011985) Renin [Units/volume] in Plasma

659

1.05

0.12

1.3

75.36

60.31

mu/l

0.22

586

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

116

0.86

0.12

1.8

1.6

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

157

0.89

0.11

1.1

94.56

93.81

—

118

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

383

0.94

0.10

1.0

1.2

98.00

170.00

titre

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

622

1.05

0.10

1.2

1.3

258.00

295.25

pmol/l

0.62

519

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

146

0.89

0.10

1.2

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

280

0.93

0.10

1.6

1.4

0.83

4.30

—

(40768446) Kidney Pathology biopsy report

154

1.10

0.10

1.5

1.6

—

(3023410) Appearance of Cerebral spinal fluid

412

0.95

0.09

1.5

1.4

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.09

0.09

1.2

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.06

0.09

1.0

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

193

1890

1.02

0.09

1.1

163.75

220.91

titre

—

(3003740) Influenza virus B Ag [Presence] in Specimen

380

0.95

0.09

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

380

0.95

0.09

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

126

1.11

0.09

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

194

1.08

0.09

2.6

2.8

32.82

28.51

umol/l

0.87

143

(3047189) Immunofixation for 24 hour Urine

194

1.08

0.09

1.5

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.05

0.08

7.7

10.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.05

0.08

1.5

1.1

—

(3007916) DNA double strand Ab [Titer] in Serum

0.83

0.08

1.0

1.2

—

86.98

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

307

0.94

0.07

1.0

1.1

5.58

2.80

u/ml

0.39

152

(3000492) Spirometry study

416

4206

0.99

0.07

1.4

1.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

571

0.96

0.07

1.7

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

0.80

0.07

1.0

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

225

1.07

0.07

1.5

1.4

0.21

0.26

nmol/l

0.29

178

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

712

0.97

0.07

1.7

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4610

46166

0.99

0.07

4.5

4.7

2.74

2.06

mu/l

0.63

4072

41429

(3036180) Methadone [Presence] in Urine

1.06

0.07

1.4

1.5

—

(3051593) INR in Capillary blood by Coagulation assay

314

1.05

0.07

19.7

10.2

—

(3024932) HLA-DR beta [Type]

0.89

0.06

1.0

—

(3024471) HLA-A [Type]

0.86

0.06

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

103

0.87

0.06

4.1

7.6

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

671

1.03

0.06

1.5

1.6

0.81

0.84

g/l

0.10

507

(3001964) Herpes simplex virus Ag [Presence] in Specimen

121

0.91

0.06

1.0

1.3

—

(3003129) Base excess in Capillary blood by calculation

149

1.07

0.05

2.2

1.5

0.30

0.57

mmol/l

0.11

143

(3024263) Appearance of Synovial fluid

303

0.96

0.05

1.3

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

110

0.91

0.05

1.0

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

239

1.05

0.04

1.0

1.1

1.23

0.27

u/ml

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

351

0.97

0.03

1.0

1.1

0.90

1.43

u/ml

0.52

179

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

108

0.93

0.03

1.7

1.5

174.50

114.29

ng/l

—

108

(3036071) Salmonella sp Ab [Titer] in Serum

108

0.93

0.03

1.0

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

102

1008

1.01

0.02

1.6

1.7

7.15

4.55

iu/l

0.53

311

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

162

1632

0.99

0.02

1.5

1.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

571

1.02

0.02

1.6

1.3

142662.63

206383.17

e6/l

0.27

393

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

127

0.94

0.01

1.6

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

491

4895

1.00

0.01

1.3

1.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

203

1.03

0.01

1.0

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

447

0.98

0.01

1.4

1.3

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

124

1.05

0.00

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

124

1.05

0.00

4.6

7.8

—

(4062490) Immunoglobulin typing, IgG

436

0.99

0.00

1.1

1.4

—

(3020650) Glucose [Presence] in Urine

107

1.03

0.00

1.2

1.5

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

219

1.00

0.00

1.3

1.2

—

(3025130) Human papilloma virus identified in Specimen

316

1.01

0.00

1.3

1.7

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

150

1.00

0.00

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

625

1.01

0.00

1.2

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

120

1.00

0.00

1.7

1.5

67.00

74.62

nmol/24h

0.38

120

(3036670) Protein [Mass/volume] in Synovial fluid

199

1.00

0.00

1.2

40.12

39.28

g/l

0.07

100

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

131

0.99

0.00

1.7

1.4

9.75

9.18

ug/l

0.25

131

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

143

0.98

0.00

1.0

1.1

1973.50

1728.60

miu/ml

0.28

143

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

557

1.01

0.00

1.6

1.5

27.59

28.72

0.09

362

(3028192) IgG subclass 2 [Mass/volume] in Serum

435

1.01

0.00

1.1

1.4

3.19

2.96

g/l

0.35

304

(3027135) IgG subclass 1 [Mass/volume] in Serum

435

1.01

0.00

1.1

1.4

7.35

6.86

g/l

0.39

303

(3024139) IgG subclass 3 [Mass/volume] in Serum

435

1.01

0.00

1.1

1.4

0.54

0.42

g/l

0.65

306

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

192

0.99

0.00

3.2

5.4

63.50

70.17

0.41

161

(3028679) Herpes simplex virus Ab [Presence] in Serum

159

1.01

0.00

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.00

0.00

1.1

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

0.0

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.91

-0.00

1.6

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

35.64

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3034614) HLA Ag [Interpretation]

0.00

-0.00

0.0

1.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.86

-0.00

1.0

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.89

-0.00

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.3

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

1462.86

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

11.31

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

1.40

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

2.1

—

1.93

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.9

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.94

-0.00

1.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

7.3

—

0.24

—

(3014171) Thiocyanate [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

121.40

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

-0.00

0.0

2.1

—

(3016135) IgD [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

298.06

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

-0.00

0.0

3.9

—

18.14

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_COLON – Malignant neoplasm of colon

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of colon

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Malignant neoplasm of colon (C3_COLON)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints